Sex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Sex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption Christopher J. Petty, Mindy Isaman, Laura Pallas Perez, Sophie Millard, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-9557496/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 4 You are reading this latest preprint version Abstract Background Obesity continues to be a public health issue in our country. Additionally, there continues to be a higher incidence of severe obesity for women compared to men. Among the proposed causes of obesity is increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor. Emerging evidence shows that the gut microbiome impacts feeding behavior and studies have shown that individuals with obesity exhibit an altered gut microbiome. Methods Here, we used a novel behavioral economics (BE) approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet, before and after antibiotic administration. Specifically, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q 0 ), a prediction of consumption at null effort extrapolated from the animals’ consumption at low price. Results We determined a higher demand at null cost (Q 0 ) for the HFP reward pellet for females compared to males, as we have observed previously. Next, we administered an antibiotic cocktail in the drinking water to disrupt the gut microbiome and investigate a role of the gut microbiome in hedonic feeding. Female rats administered antibiotics continued to have a higher demand at null cost compared to male control rats, but no statistically significant differences were determined between male and female rats administered antibiotics. We characterized the fecal microbiome genus-level composition and short chain fatty acid (SCFA) levels before and after antibiotic administration. We also characterized serum SCFA and bile acid levels at the end of the study. Conclusions We did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. Additionally, we did not observe striking baseline sex differences in fecal microbiome diversity and composition. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome – bile acid effects on feeding that exhibit sex differences. gut microbiome hedonic feeding sex differences antibiotics behavioral economics short chain fatty acids bile acids Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Plain English summary Obesity incidence has continued to rise in the United States as well as the world. The prevalence of obesity affects more women than men, especially severe obesity. Some of the proposed causes of obesity/severe obesity are increased access to calorie-dense foods, decreased energy expenditure, and increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor as the widespread availability of palatable foods can lead to chronic overconsumption. We evaluated hedonic feeding using a behavioral economics approach in male and female rats. We also characterized the fecal microbiome and multiple metabolites related to the gut microbiome. This study aimed to evaluate the role of the gut microbiome in sex differences in hedonic feeding. We determined that female rats consume more of the high fat, high sugar reward compared to males under no-cost conditions of the behavioral economics paradigm. However, we did not determine significant differences in the composition of the gut microbiome at the genus level that could explain the sex differences in hedonic feeding. Lastly, we characterized sex differences in the bacterial composition of the fecal microbiome, fecal and serum short chain fatty acid, and serum bile acid composition following antibiotic treatment. More research will be necessary for network factors such as microbiome – bile acid effects on feeding that exhibit sex differences. Background Obesity (body mass index ≥ 30) and severe obesity (body mass index ≥ 40) prevalence in the United States have increased between 2000 and 2023 from 30.5% to 40.3% and 4.7% to 9.4%, respectively (CDC). Specifically, the prevalence of obesity for adult women in 2000 was 33.4% compared to 27.5% for adult men. In 2023, the prevalence of obesity for adult women was 41.3% compared to 39.2% for adult men. The prevalence of severe obesity for adult women in the United States was 6.2% in 2000 compared to 3.1% for adult men; it was 12.1% for adult women in 2023 compared to 6.7% for adult men [ 3 ]. Sex differences in obesity prevalence have decreased as obesity rates have risen, but the sex differences in severe obesity remain. Among the proposed causes of obesity/severe obesity are increased access to calorie-dense foods, decreased energy expenditure, and increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor as the combination of food-driven reward seeking and widespread availability of palatable foods can lead to chronic overconsumption. Sex differences in palatable food consumption have been determined in preclinical studies. Female rats consume more palatable food and escalate their intake faster compared to males [ 4 – 7 ]. We have previously shown that females have a higher demand at null cost for three different palatable rewards using a behavioral economics (BE) single-session paradigm, a de-escalating fixed ratio operant task designed to evaluate a reward’s value and measure how much effort the subject is willing to expend to earn that reward [ 8 ]. These sex differences in hedonic feeding could provide support for observed sex differences in severe obesity. One factor that impacts feeding behavior is the gut microbiome composition [ 9 – 11 ]. Germ-free mice consume more sucrose compared to controls when administered a high concentration of sucrose solution. Male mice given antibiotics to deplete their gut microbiome have been shown to consume more sucrose pellets compared to vehicle controls. Furthermore, antibiotic-treated mice that received fecal transplants from specific pathogen-free donors reduced sucrose pellet consumption, comparable to vehicle controls [ 9 ]. These findings suggest that the microbiome plays a role in reward-driven feeding. Studies have also shown that individuals with obesity exhibit an altered gut microbiome [ 12 ]. This difference in the microbiome has been studied in animal models as well, revealing that a fecal microbiota transplant from obese to germ-free mice leads to weight gain in the mice that received the obese microbiota profile [ 12 , 13 ]. Here, we used a novel, behavioral economics approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet before and after antibiotic administration. This behavior analysis focused on hedonic feeding behavior; animals were not obese. Specifically, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q 0 ), a prediction of consumption at null effort extrapolated from the animals’ consumption at low price. We determined a higher demand at null cost for the HFP reward pellet for females compared to males, as we have observed previously [ 8 ]. Furthermore, we investigated hedonic feeding behavior before and after antibiotic administration; an antibiotic cocktail was administered in the drinking water for one month in order to disrupt the gut microbiome. We analyzed hedonic feeding behavior, homecage chow consumption, body weights, fecal microbiome composition and diversity, fecal and serum short chain fatty acid composition, and serum bile acid composition. While demand at null cost (Q 0 ) values were significantly different between Male Control and Female Control as well as Male Control and Female Antibiotics pre-treatment, we did not determine a statistically significant difference between any of the groups post-treatment. Overall, there was no sex difference in hedonic feeding in post-treatment groups and antibiotics did not have a statistically significant effect on hedonic feeding; however, antibiotics did alter the fecal microbiome and decreased fecal SCFA, serum SCFA, and serum bile acid composition. Methods Animals Male and female Sprague Dawley rats (Charles River Laboratories; n = 45) were individually housed and kept on a reverse 12-hour-light schedule, with behavior experiments occurring during the dark cycle. In order to monitor food consumption, water intake, and the fecal microbiome, rats were housed individually, as done previously in other dietary studies [ 8 , 16 – 19 ]. Despite single housing, rats were housed in the same room to expose them to olfactory, visual, and auditory stimuli produced by other subjects and were therefore not completely isolated [ 20 ]. Rats were frequently handled due to daily training or testing throughout the study. Rats had ad libitum access to chow (PicoLab ® Laboratory Rodent Diet 5L0D, irradiated, Lab Supply, Northlake, TX), consisting of 13% calories from fat, 58% from carbohydrates, and 29% from protein, and water throughout the duration of the experiment outside of the antibiotic phase where water was substituted with an antibiotic cocktail for a subgroup of rats. Body weights, food consumption, and water intake were monitored weekly throughout the study. Body weights were also monitored daily during BE testing phases; we normalize Q 0 values to body weight so we needed daily measurements for those calculations. All protocols and procedures followed the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the Furman University Institutional Animal Care and Use Committee. Reward Pellet During BE training and testing, a high-fat palatable (HFP) 45 mg pellet (Bio-Serv, Frenchtown, NJ) was utilized (0.72 kcal/g protein, 2.11 kcal/g fat, 1.77 kcal/g carbohydrate; Product #F06162). Hydrogenated cottonseed oil and soybean oil constitute the fat sources in this food reward. This pellet also contains dextrose and sucrose contributing to the palatability. In addition to the nutrients mentioned above, the pellet contains a standard mineral and vitamin mix. Study Design Rats were trained to press an active lever for the HFP pellet in an operant chamber (Med Associates) housed inside a sound-attenuating cubicle. The cubicle contained a red house light, two retractable levers with white cue lights above them, a food hopper, and a tone generator to reinforce the pressing of the active lever inside the chamber. Rats were trained on fixed ratio 1 (FR1) training followed by FR3, FR10, FR32, and FR100, each for a minimum of 2 days, during which they had to meet criteria for at least 50 lever presses (except FR100, which did not have a minimum lever press criteria and was only administered one day to avoid extinction). Animals not progressing through the fixed ratio training were removed from the study (n = 11 males and n = 2 females). After one day of FR100 training, rats started the BE testing. During the 105-minute BE session, a 5-minute "active period" was signaled by the house light's illumination and the levers' extension. During the active periods, responses to the active lever delivered the reward pellets on an FR schedule. The first active period was the highest schedule of reinforcement at FR100, followed by FR32, FR10, FR3, and finally, FR1. There was no maximum for pellets earned during testing. Instead, 20-minute time-out periods signaled darkness in the chamber and retraction of the levers; the time-out and the reverse order of FR schedules were employed to limit satiation. Responses on an inactive lever were not reinforced. This design produced full demand curves. Rats were administered at least 6 BE sessions until α (demand elasticity) varied less than 25% across the last three days. While this novel, behavioral economics approach includes all FR values during a single session, multiple testing sessions allow for assessment of consistent behavior, providing a “stable” α value and the associated Q 0 value for that session. Once the rats reached a stable baseline α, they were treated with an antibiotic cocktail containing 0.5g/L of vancomycin, 1.0g/L ampicillin, and 1.0g/L neomycin added to the homecage drinking water (Cayman Chemical Company, Ann Harbor, MI). Antibiotic water was monitored and changed twice weekly. After one month of antibiotic treatment, the rats completed a second round of BE testing, following the abovementioned protocol. The antibiotic water also continued during this second round of BE testing. A control group received normal drinking water for one month and then completed BE testing, still receiving normal drinking water. After completion of the protocol, rats were euthanized and trunk blood was collected. Fecal Microbiome Analysis Fecal samples were collected via sterile technique on days 5 and 6 of the initial BE testing as well as on days 5 and 6 of the second BE testing. Samples were sent to Clemson University Genomics and Bioinformatics Facility (CUGBF) for extraction, library preparation, and sequencing. DNA was extracted from fecal pellets with the DNeasy UltraClean Microbial kit (Qiagen, #1224-50). Library preparation and 16S rRNA gene amplicon sequencing was conducted following the protocol developed by Kozich et al. [ 21 ]. Briefly, the V3-V4 region of the 16S rRNA gene was PCR-amplified using barcoded dual-index primers. Upon confirmation of a correctly sized PCR product using gel electrophoresis (Invitrogen, #G401002), PCR products were normalized using the SequelPrep plate kit (Life Technologies, #A10510-01) and pooled per 96-well plate. Each pool was quantified using qPCR (KapaBiosystems, #KK4854) and sized using the Agilent Bioanalyzer high-sensitivity DNA kit (Agilent, #5067 − 4642). Multiplexed pooled amplicon libraries were sequenced paired end 2 x 300 cycles on the Illumina NextSeq2000 platform with a 10% PhiX spike according to manufacturer’s protocol. Initial amplicon sequence processing was conducted in QIIME2 v.2024.2 [ 22 ]. Raw sequences were quality filtered, denoised, and assigned to Amplicon Sequence Variants (ASVs) using the DADA2 plugin [ 23 ]. Representative sequences were aligned using a multiple sequence alignment program (MAFFT) and a phylogenetic tree was generated with fasttree [ 24 ]. ASVs taxonomy were assigned using the SILVA 138 database. The final ASVs table was rarefied to 25.9k reads per sample and used for subsequent analyses. Short Chain Fatty Acid (SCFA) and Bile Acid Analysis The Duke Proteomics and Metabolomics Core Facility performed SCFA and bile acid analysis. Each fecal sample (50–100 mg) was placed in bead blaster CK-14 homogenization tubes (Bertin Corp) and homogenized using the Precellys 24 bead blaster (Bertin Instruments) at 4°C for three cycles of 10 seconds each at 10,000 rpm, with a 60-second pause between bursts. After homogenization, sample extracts underwent centrifugation at 15,000 relative centrifugal force for 15 minutes at 4°C. Data collection utilized LC–MS/MS on a Waters Xevo TQ-S mass spectrometer. Calibration curves were established for each analyte, and a 13 C 6 internal standard was used for compound quantification (via 13 C 6 NPH derivatization reagent). Data analysis was performed using Skyline software ( www.skyline.ms ), with initial concentrations reported in µM. To convert concentrations, the mass of feces homogenized and extracted was included, along with the volume of solvent added, resulting in nmol/mg concentrations. Serum samples were also analyzed for SCFAs. This analysis was performed with the Sciex QTrap 6500 + system (Framingham, MA) with Waters Acquity I-class plus UPLC. Software Analyst 1.7.3 was used for data acquisition. For sample preparation, 20 µL serum was mixed with 40µL ethanol, and then kept at -20 o C for 20 min, followed by vortex and then centrifugation at 15,000 rcf for 4 minutes at 10 o C. All data was analyzed in Skyline v23.1.0.455 ( www.skyline.ms ) which includes raw data import, peak integration, and a quadratic regression fit with 1/x2 weighting for the calibration curves for SCFA. The SCFA method quantified 12 SCFAs commonly found in biological samples: acetic acid, propionic acid, iso-butyric acid, butyric acid, 2-methyl butyric acid, iso-valeric acid, valeric acid, 3-methyl valeric acid, iso-caproic acid, caproic acid, heptanoic acid, and octanoic acid. This validated method is based on previous work published by Han et al. [ 25 ]. Serum samples were analyzed with the Biocrates Bile Acids assay (Biocrates, Innsbruck, Austria), which quantifies 20 bile acids. The serum samples were centrifuged at 10,000 rcf for 2 minutes in a refrigerated (4°C) centrifuge then stored on ice until addition to the bile acids kit plate. Samples were prepared in strict accordance with the Biocrates detailed protocol. Addition of 10 µL of the supplied internal standard solution to each well of the 96-well extraction plate was followed by drying under a gentle stream of nitrogen. Study samples, calibration standards, and QCs were added in 10 µL aliquots to the appropriate wells. The plate was then dried a second time under a gentle stream of nitrogen. The samples were eluted with methanol then diluted with water. Sample analysis of bile acids was performed by a Waters ultra-high pressure liquid chromatography (UPLC) tandem mass spectrometric method using a reversed phase analytical column for analyte separation. Selective analyte detection was accomplished by use of a Xevo TQ-S triple quadrupole tandem mass spectrometer operated in multiple Reaction Monitoring (MRM) mode, in which specific precursor to product ion transitions were measured for every analyte and stable isotope labeled internal standard. Pools of the study samples (SPQC) were injected before, during, and after the study samples in order to measure the performance of the assay across the sample cohort. The UPLC-MS/MS data were directly imported into Biocrates WebIDQ™ software for peak integration, calibration, and concentration calculations. Estrus Cycle Analysis During BE testing, the estrus cycle was evaluated via vaginal lavage. Female rats were acclimated to the action of a vaginal lavage beginning on the first day of FR32 training through the action of handling and imitation of the lavage with an empty and sterile transfer pipette. Therefore, females were acclimated to vaginal lavage prior to BE testing. When the rats entered the testing phase, researchers collected cell samples via vaginal lavage using a 0.9% NaCl solution until stabilization on the BE task occurred. Collected samples were smeared onto a glass slide, stained with Quik-Dip Hematology Stain (Mercedes Medical, FL) and evaluated under the microscope in order to characterize the cycle phase (estrus, proestrus, diestrus, and metestrus). The cycle phase during the test day that a stable α value was reached is shown in Fig. 2 B. Statistical Analysis Statistical tests were completed using GraphPad Prism (GraphPad Software, La Jolla, California, USA, www.graphpad.com ) and R v.4.4.1. Body weight gain, food consumption, water consumption, BE values, and fecal SCFAs were analyzed using a linear mixed-effects model with Time (pre vs post), Sex, and Treatment as fixed effects and animal ID as a random effect. Tukey’s multiple comparisons test was conducted to correct for multiple testing. Serum bile acids and SCFAs were analyzed using a one-way ANOVA since serum was only collected at the end of the study; a pre vs post analysis was not conducted. Microbiome diversity analyses were performed in R v.4.4.1 using phyloseq [ 26 ], vegan [ 27 ] and microeco packages [ 28 ]. In alpha-diversity, the Kruskal–Wallis rank-sum test was subsequently used to calculate the significance of mean differences in variables between treatments, and the pairwise Wilcoxon rank-sum test was used to compare significant differences between groups [ 29 ]. P-value correction for multiple testing was performed according to the Benjamini-Hochberg FDR method [ 30 ]. Beta diversity was assessed using Principal Coordinates Analysis (PCoA) [ 31 ] based on Bray–Curtis and Weighted Unifrac distance matrices. Permutational Multivariate Analyses of Variance (PERMANOVA), with 999 permutations, was used to test for significant differences between groups [ 29 ]. Variations within communities were determined by distance-based tests for homogeneity using the betadisper function [ 32 ]. Differential abundant taxa were determined using LEfSe (Linear discriminant analysis Effect Size) [ 33 ]. Co-occurrence networks at genera level were constructed for water- and antibiotic-treated groups. ASVs with low relative abundance were removed and Spearman correlations were calculated with Benjamini-Hochberg FDR P value correction [ 30 ]. Only significant relationships with a correlation coefficient (ρ) ≥ ± 0.6 and P < 0.01 were selected and translated into networks. The networks were further visualized using the interactive platform Gephi v.0.10.1 [ 34 ]. Results The percentage of body weight gain (change in weight divided by starting weight), from the start of the experiment to the end of the first session of BE testing (Pre-Treatment), and then the end of the first session of BE testing to the end of the second session of BE testing (Post-Treatment), was compared between four groups: Male Control, Male Antibiotics, Female Control, Female Antibiotics (Figure 1A). A significant sex x treatment effect was determined (F(3,56) = 10.78, p <0.0001). Pre-treatment, Male Control gained significantly more weight than Female Control ( p <0.0001) and Female Antibiotics ( p = 0.0048). Male Antibiotics also gained significantly more weight than Female Control ( p = 0.0128). These changes in body weight were prior to antibiotic treatment, or control, water treatment; this confirms no statistically significant differences for Male Control vs. Male Antibiotics and Female Control vs. Female Antibiotics at baseline. There were no statistically significant differences in body weight gain post-treatment. Homecage chow consumption (Figure 1B) and water consumption (Figure 1C) were evaluated weekly throughout the study. Average food consumption and water consumption, pre-treatment and post-treatment, were normalized to the animal’s body weight. There was a significant sex x treatment effect (F(3,27) = 6.649, p = 0.0017), time effect (F(1,27) = 80.27, p < 0.0001), and sex x treatment x time interaction effect (F(3,27) = 7.165, p = 0.0011) for food consumption. Female Control consumed significantly more homecage food (normalized to body weight) compared to Male Control ( p = 0.0492) and Male Antibiotics ( p = 0.0389), pre-treatment. Female Antibiotics consumed significantly more homecage food compared to Male Control ( p = 0.0074) and Male Antibiotics ( p = 0.0052), pre-treatment. Given that these were baseline, pre-treatment measurements, no statistically significant differences between Male Control and Male Antibiotics or Female Control and Female Antibiotics were observed, as expected. Post-treatment, Female Control continued to consume more homecage food compared to Male Control ( p = 0.0169) and Male Antibiotics ( p = 0.0004). Post-treatment, Female Antibiotics consumed less homecage food, but this was not significantly different from Female Control ( p = 0.3394). There was a significant sex x treatment effect for water consumption (F(3,27) = 7.677, p = 0.0007) and a sex x treatment x time interaction effect (F(3,25) = 4.813, p = 0.0088). Pre-treatment, Female Antibiotics consumed significantly more water than Male Control ( p = 0.0411). Post-treatment, Female Antibiotics drank more water compared to all other groups: Female Antibiotics vs. Male Control: p < 0.0001, Female Antibiotics vs. Male Antibiotics: p < 0.0001, and Female Antibiotics vs. Female Control: p = 0.0052. Given that females drank the most antibiotic water, they did receive a higher dose of antibiotics compared to males ( p <0.0001). A significant sex x treatment effect was determined for Q 0 values (F(3, 28) = 6.477; p = 0.0018). Q 0 values were significantly higher ( p = 0.0119) for Female Control compared to Male Control (Figure 2A). Female Antibiotics Q 0 was also significantly higher than Male Control ( p = 0.0016). There was no statistically significant difference between Male Antibiotics and Female Antibiotics ( p = 0.0627). There was also no statistically significant difference for Male Control vs. Male Antibiotics ( p = 0.5019) or Female Control vs. Female Antibiotics (p = 0.2747). If pre-treatment groups are collapsed and compared by sex: female pre-treatment has significantly higher Q 0 values compared to male pre-treatment ( p = 0.0110) as determined by Welch’s t-test. Q 0 individual values pre- vs. post-treatment are further compared in Figure S1. No statistically significant differences in values pre- vs. post-treatment were determined with a paired t-test within each sex and treatment group. The estrus cycle was characterized after collection of samples via vaginal lavage throughout BE testing. Female rats stabilized on the BE paradigm during the four stages of their cycle: diestrus, proestrus, estrus, and metestrus. Figure 2B displays the Q 0 values pre-treatment and post-treatment, with the estrus cycle characterized for that final day of BE testing when the female had a stable α value. There are not enough data points to conduct statistical tests on these data. No statistically significant sex or treatment differences were determined for α at any stage of the experiment (Figure 2C). Table 1 displays the average number of active and inactive lever presses as well as pellets earned for males and females during the training period, prior to the BE testing. Table 1. Average Number of Active/Inactive Lever Responses and Pellets Earned During 1-Hour FR Training Sessions Prior to BE Testing. Values are n (SEM). The composition of the fecal microbiome was altered by antibiotics. Many of the top 40 most abundant genera showed significantly decreased relative abundance following administration of the antibiotic cocktail in both male and female rats (Figure 3A). Post-antibiotics, males had increased relative abundance of Clostridia vadin BB60 and Morganellaceae compared to pre- treatment and water groups. Although not statistically significant, these genera appeared to be higher in abundance in males post-antibiotics compared to females post-antibiotics. Conversely, females showed increased relative abundance of Bacillaceae, Nocardiopsaceae, Brevibacillaceae, and Paenibacillaceae compared to pre-treatment and water groups. Once again, no statistical significance in the abundance of these genera was found between sexes after antibiotic treatment although their abundance does appear to be higher in females compared to males post-antibiotics. Linear Discriminant Analysis Effect Size (LEfSe) was used to compare the relative abundance of the top 20 genera between rats pre-and post-antibiotics (Figure 3B). Consistent with the heatmap findings, the genera showing the most significant differences in relative abundance (LDA > 3.5, p < 0.05) included Lactobacillus , Muribaculaceae , and Romboutsia , which decreased following antibiotic treatment, and Escherichia–Shigella and Enterococcus , which increased (Figure 3B). Several of these genera were also identified in genus-level co-occurrence networks, revealing patterns of positive associations among taxa in control (Figure S2A) and antibiotic-treated (Figure S2B) rats. As shown by the Principal Coordinate Analysis (PCoA) plot, a significant shift in the structure of the fecal microbiome occurred due to antibiotic treatment (PERMANOVA, p < 0.01; Figure 4A). Pre-control and pre-antibiotics samples compared to post-antibiotics revealed a statistically significant difference ( p = 0.001), pre-control samples compared to post-control did not reveal a statistically significant difference ( p = 0.63; Figure 4A). Additionally, there was a significant decrease in microbiome diversity after antibiotic treatment (Wilcoxon rank-sum test, p < 0.01) as addressed by Shannon (Figure 4B) and Inverse Simpson (Figure 4C) diversity metrics. Among post-antibiotic treated rats, there was no statistically significant difference in microbiome structure between males and females as shown by the PCoA plot (Figure S3A). For the Shannon diversity index (Figure S3B), both males and females revealed a significant decrease for post-antibiotics samples compared to post-control. Females also displayed a significant decrease for pre-antibiotics compared to post-control. For the Inverse Simpson diversity index (Figure S3C), no statistically significant difference was determined for males. Females had a decreased Inverse Simpson diversity index for post-antibiotics compared to post-control. Short chain fatty acid (SCFA) analysis in serum as well as fecal samples further revealed the effects of antibiotic treatment on the gut microbiome. All SCFAs were decreased following antibiotic treatment in both sexes. For example, the mean fecal acetic acid level for the Male Antibiotics group was 53.83 nmol/mg pre-treatment and 6.37 nmol/mg post-treatment. The mean fecal acetic acid level for the Female Antibiotics group was 59.01 nmol/mg pre-treatment and 0.99 nmol/mg post-treatment. Table 2 displays those differences in fecal SCFAs (# indicates a trend, p -values are reported); the top of the table includes mean values for fecal SCFAs (nmol/mg) by group, from samples collected prior to the antibiotic or control (water) administration. Below, are the mean fecal SCFA values (nmol/mg) by group, post-treatment, followed by statistical comparisons for the post-treatment values. No significant differences were determined for pre-treatment values. Finally, the bottom of the table includes pre vs. post-treatment statistical comparisons. Table 3 displays serum SCFA values (µM) and statistical comparisons. Serum was only collected at the end of the study. Therefore, we do not have pre vs. post-treatment comparisons, only serum SCFA comparisons by group. Three serum SCFA levels were below detection for antibiotics-treated groups: propionic acid, butyric acid, and valeric acid. Interestingly, some serum SCFAs were not significantly changed by antibiotic treatment. For example, iso-butyric acid levels were slightly increased (not statistically significant) for antibiotics-treated groups compared to control (water) groups, in both sexes. Importantly, we also observed a sex difference in serum iso-caproic acid in water groups as well as a sex difference in serum octanoic acid in antibiotics groups. Females had higher levels of iso-caproic acid compared to males, whereas males had higher levels of octanoic acid compared to females. Serum bile acid levels (µM) were also analyzed, many were reduced by antibiotic treatment, particularly for male rats (Table 4). For example, the mean serum cholic acid level for Male Control was 11.41 µM vs. 0.037 µM for Male Antibiotics. The mean serum cholic acid level for Female Control was 5.48 µM vs. 0.023 µM for Female Antibiotics. There were a wide range of serum cholic acid values for Male Control and particularly, Female Control. Therefore, a statistically significant difference for Female Control vs. Female Antibiotics was not determined. Male Antibiotics had significantly lower serum cholic acid levels compared to Male Control ( p = 0.0360). Raw values for all of these measurements are posted on FigShare: 10.6084/m9.figshare.30306424. Characterization of fecal SCFAs, serum SCFAs, and serum bile acids between males and females, with and without antibiotics, provides important information and characterization related to the gut microbiome and metabolism. Correlation analysis revealed significant associations between SCFA content, water, and home cage food consumption, and numerous specific microbial taxa (Figure 5A), whereas only a few genera were correlated with sex. SCFA content was positively correlated with 39 different genera, including the most abundant ones, such as Lactobacillus, Muribaculaceae, Romboutsia, Clostridia UCG-014, Bacteroides, and Ruminococcus . Consistent with previous results, fecal SCFA and its positively associated taxa decreased after the antibiotic treatment. Thus, SCFA content showed an inverse correlation with the genera that increase their abundances in the post-antibiotic conditions (i.e.: Clostridium sensu stricto, Escherichia-Shigella, Enterococcus, Staphylococcus , etc.). To further investigate the influence of hedonic feeding and related variables on microbial composition, a redundancy analysis (RDA) was performed (Figure 5B). The model identified propionic, isovaleric, and 2-methylbutyric acids as the most significant drivers of the community structure across treatments (adj. p -value < 0.01). These 3 fatty acids were the main predictors of the microbial communities for pre-control, pre-antibiotics, and post-control samples, while they showed a negative association with post-antibiotic samples. Table 2. Fecal SCFA Composition Analyses. Mean fecal SCFA levels reported in nmol/mg. Pre-treatment: Male Control (n = 3), Male Antibiotics (n = 8), Female Control (n = 6), Female Antibiotics (n = 6). Post-treatment: Male Control (n = 5), Male Antibiotics (n = 8), Female Control (n = 5), Female Antibiotics (n = 7). Table 3. Serum SCFA Composition Analyses . Mean serum SCFA levels reported in µM. Male Control (n = 6), Male Antibiotics (n = 7), Female Control (n = 7), Female Antibiotics (n = 5). Table 4. Serum Bile Acid Composition Analyses. Mean serum bile acid levels reported in µM. Male Control (n = 6), Male Antibiotics (n = 7), Female Control (n = 6), Female Antibiotics (n = 5). Discussion First, we determined that females have a higher demand at null cost for the high fat palatable reward compared to males. We have previously shown this sex difference [ 8 ]. However, in our previous study, males and females were mildly food restricted in order to encourage lever pressing for the palatable rewards. Here, we provided ad libitum access to homecage food and continued to see lever pressing behavior to produce full demand curves. However, more males (n = 11) failed to reach criteria during BE training with ad libitum homecage feeding compared to females (n = 2) due to lower lever-pressing for the pellet, further supporting the finding that females have a higher demand for this palatable reward compared to males. Second, we characterized hedonic feeding, homecage feeding, fecal microbiome composition and diversity, serum and fecal SCFA composition, and serum bile acid composition following disruption of the gut microbiome with antibiotics. An antibiotic cocktail was utilized to disrupt the gut microbiome and test whether diversity of the gut microbiome impacted hedonic feeding behavior. In order to control for time between BE sessions as well as repeated sessions, we also included a subgroup of animals given normal drinking water for one month instead of the antibiotic cocktail. We did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. A mixed-effects analysis for time x sex x treatment and Tukey’s multiple comparisons test was applied; Female Control and Female Antibiotics had a significantly higher Q 0 value compared to Male Control pre-treatment. No significant differences were determined between Female Control and Female Antibiotics, Male Control and Male Antibiotics, or Male Antibiotics and Female Antibiotics pre-treatment. No statistically significant differences in Q 0 were determined for any group post-treatment. We did not determine any statistically significant differences in α between groups or between time points. Male Antibiotics had a slightly higher mean α value after antibiotics treatment, indicative of lower motivation, but that is not statistically significant. Importantly, this behavior analysis focused on hedonic feeding behavior; animals were not obese. Females consumed more water (normalized to their weight) during antibiotic treatment. Therefore, females received a higher dose of antibiotics compared to males. We noted temporary, reduced water consumption in male rats as well as weight loss, which may be related to an aversion to the taste of antibiotics. Previous work has shown that changes in drinking and feeding are not fully attributable to the bitter taste of antibiotics [ 42 ]. Studies have shown that females exhibit enhanced taste perception compared to males, particularly for bitter flavors, as well as sweet and salty tastes [ 43 , 44 ]. Complementing enhanced taste perception for females, enhanced olfaction has also been shown for females [ 45 – 47 ]. Therefore, decreased consumption of the antibiotic cocktail is likely not fully explained by taste aversion in males. In a study by Parodi et al. (2022), male and female Sprague-Dawley rats had significantly different responses to eight days of an antibiotic cocktail in their drinking water. Their antibiotic cocktail included the same antibiotics as our cocktail, however, it also included 1 g/L metronidazole. We chose not to include metronidazole in our current study given that it crosses the blood-brain barrier [ 48 ]. Similar to our findings, males and females exhibited significant differences in microbiome composition as well as body weight in response to the antibiotics. Their study also determined that males and females experienced weight loss during antibiotic treatment, however, females recovered their body weights after antibiotic treatment ended, while males did not [ 38 ]. We collected fecal samples during both rounds of BE testing. We compared diversity and composition of the fecal microbiome between groups and time points. We, and others, have previously observed baseline sex differences in fecal microbiome composition and diversity for C57Bl/6 mice [ 36 , 49 – 52 ]. We did not observe striking baseline sex differences in our current study with Sprague-Dawley rats. We hypothesized that sex differences in the gut microbiome contribute to sex differences in hedonic feeding. Given that there were no baseline sex differences in the fecal microbiome composition and disruption of the gut microbiome with antibiotics did not result in significant differences in hedonic feeding, our hypothesis was not supported. It may still be possible that the gut microbiome contributes to sex differences in hedonic feeding, even though our results do not support this claim. We consider a number of possibilities and limitations of our current study: 1) fecal samples were collected during BE testing in order to make within-animal comparisons (for example, pre-antibiotics and post-antibiotics within the same subject). A future study could, instead, collect samples directly from the colon to more accurately characterize aerobic and anaerobic bacteria. However, in this alternative experimental design, we could only evaluate behavior one time and then euthanize the animal to collect the samples. Still, there are other bacteria that are not fully captured with our current method. Furthermore, the gut microbiome is influenced by viruses, yeast, fungi, and archaea; there could be sex differences in these microorganisms that impact hedonic feeding. 2) Our current study evaluated adult rats and does not take into account the timeline during which the microbiome affects the circuitry for hedonic feeding. If the microbiome shapes hedonic feeding circuitry, it is likely that this occurs early in development. The behavioral economics paradigm was implemented during adulthood due to the complexity of the task and size of the operant chamber/position of levers that could be more difficult for younger rats to complete. The hedonic feeding circuitry could be less plastic during adulthood. 3) The antibiotic cocktail was administered in the drinking water. An alternative experimental design could include oral gavage of the antibiotics to control dosage. However, repeated oral gavage can be stressful and can affect the gastrointestinal tract. Therefore, we chose the less invasive strategy of antibiotic cocktail administration via their homecage water bottles. We did observe decreased consumption by male rats compared to female rats when we normalized consumption and dosage to body weight. Ultimately, we observed disruption of the fecal microbiome for both male and female rats. We also observed decreased SCFAs in male and female antibiotic-treated rats, indicating disruption of the gut microbiome to impact these metabolites in both sexes. In addition to analyzing fecal microbiome diversity and genus-level composition, we characterized fecal SCFAs, serum SCFAs, and serum bile acids. SCFA analysis can provide more information about microbiome metabolism. For example, it is known that Clostridium, Butyrivibrio , and Eubacterium are major producers of butyric acid [ 53 ]. Following antibiotic administration, we determined significant decreases in fecal and serum SCFAs for both males and females. We did determine a significant sex difference for serum iso-caproic acid for control groups and serum octanoic acid for antibiotic groups. Females had higher levels of iso-caproic acid compared to males, and higher levels following antibiotic treatment. Males had higher levels of octanoic acid compared to females, and higher levels following antibiotic treatment. We did not observe sex differences for these SCFAs in fecal samples. Fecal samples had significantly lower iso-caproic levels and octanoic acid levels for both sexes after antibiotics. However, in a previous study with C57Bl/6 mice we did observe a sex x dietary treatment/antibiotic treatment effect for fecal octanoic acid (among other SCFAs): males fed a low-fat diet had higher levels of octanoic acid than all other groups [ 35 ]. The observed differences in serum SCFAs in the current study could be due to differences in fatty acid metabolism, which has already been shown to be different in males and females [ 35 , 54 , 55 ]. Fatty acid utilization, lipid sensing, and lipid taste can impact hedonic feeding [ 56 – 58 ]. We further analyzed serum bile acid concentrations. Bile acids are synthesized in the liver, affect gastrointestinal hormone secretion, and they are also known to impact appetite, glucose metabolism, and lipid metabolism. For example, supplementation with cholic acid has been shown to reverse adiposity in mice administered a high fat diet [ 59 ]. In that study, chow-fed animals were not affected by the cholic acid supplementation. The high fat-fed, obese mice exhibited decreased white adipose tissue as well as improved glucose tolerance after cholic acid supplementation [ 59 ]. On the other hand, administration of deoxycholic acid to high fat-fed mice revealed increased hepatic ER stress, reduced hepatic insulin signaling, and impaired glucose homeostasis [ 60 ]. Bile acid subtypes have variable effects on glucose metabolism. Here, we determined significant changes to many bile acid subtypes following antibiotic administration, particularly for male rats. Antibiotics had less of an effect on bile acid concentrations for female rats. For example, cholic acid was significantly reduced in antibiotic-treated males ( p = 0.0360), but not in antibiotic-treated females ( p = 0.7208) because females already had lower levels of cholic acid. We also determined a significant sex difference: Female Control had higher levels of lithocholic acid compared to Male Control ( p = 0.0007). Lithocholic acid (LCA) was significantly reduced post-antibiotics for female rats ( p = 0.0020). Interestingly, LCA is increased after calorie restriction, it has been shown to activate AMPK [ 61 ], it decreases blood glucose levels, and it increases plasma GLP-1 levels [ 62 ]. Furthermore, it is known that Lactobacillus, Clostridium and Eubacterium species convert cholic acid and chenodeoxycholic acid to lithocholic acid [ 63 ]. We also determined significant sex differences in taurochenodeoxycholic (TCDCA). Females had higher levels of TCDCA compared to males, which increased even further with administration of antibiotics; that increase in TCDCA post-antibiotics was not observed for males. TCDCA is a conjugated bile acid that has been shown to increase following high fat feeding [ 64 ]. Previous work has demonstrated that microbiome changes due to high fat feeding can lead to increased TCDCA levels which can activate the farnesoid X receptor (FXR) and induce insulin resistance [ 64 , 65 ]. The composition of the gut microbiome has been shown to impact feeding behaviors. We did not determine major sex differences in the gut microbiome here that could contribute to our observed sex differences in hedonic feeding. Conclusions We determined that female Sprague-Dawley rats have a higher demand at null cost for a high fat palatable reward compared to male Sprague-Dawley rats. We also determined that administration of antibiotics did not significantly change hedonic feeding behavior; however, sex differences in Q 0 values did not persist following antibiotic administration. Furthermore, we did not observe striking baseline sex differences for gut microbiome composition and diversity in our current study with Sprague-Dawley rats. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome – bile acid effects on feeding that exhibit sex differences. Declarations Ethics approval and consent to participate: All protocols and procedures followed the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the Furman University Institutional Animal Care and Use Committee. Consent for publication: Not applicable. Availability of data and material: Raw sequence data have been deposited in the Sequence Read Archive (Project PRJNA1337140): https://www.ncbi.nlm.nih.gov/sra?linkname=bioproject_sra_all&from_uid=1337140. The behavior, short chain fatty acid, and bile acid datasets are available at FigShare: 10.6084/m9.figshare.30306424. Competing interests: The authors declare that they have no competing interests. Funding: Research reported in this publication was supported by the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health under Award Number R15DK136098. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This publication was made possible, in part, with support from the Clemson University Genomics and Bioinformatics Facility, which receives support from the College of Science and two Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20GM146584 and P20GM139769. Authors' contributions: C.J.P., M.I., and L.P.P. conducted behavioral economics training and testing as well as animal husbandry. M.O. and S.M. conducted next-generation sequencing, statistical analyses, and contributed Figures 3, 4, 5, S2, and S3. L.R.F. obtained funding for the project, planned experiments, conducted analyses, helped draft the manuscript, and contributed the other figures. All authors contributed to the writing and editing of the manuscript. All authors read and approved the final manuscript. Acknowledgments: We thank the Duke University School of Medicine for the use of the Proteomics and Metabolomics Core Facility, which provided short chain fatty acid and bile acid analysis service. Authors’ information: Not applicable. References Anversa RG, Muthmainah M, Sketriene D, Gogos A, Sumithran P, Brown RM. A review of sex differences in the mechanisms and drivers of overeating. Front Neuroendocrinol. 2021;63:100941. 10.1016/j.yfrne.2021.100941 . Asarian L, Geary N. Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol. 2013;305 11:1215. 10.1152/ajpregu.00446.2012 . Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023. NCHS Data Brief. doi 2024;508(508). 10.15620/cdc/159281 . Hardaway JA, Crowley NA, Bulik CM, Kash TL. Integrated circuits and molecular components for stress and feeding: implications for eating disorders. Genes Brain Behav. 2015;14 1:85–97. 10.1111/gbb.12185 . Carlin JL, McKee SE, Hill-Smith T, Grissom NM, George R, Lucki I, et al. Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice. Neuroscience. 2016;326:170–9. 10.1016/j.neuroscience.2016.04.002 . Babbs RK, Wojnicki FHE, Corwin RLW. Assessing binge eating. An analysis of data previously collected in bingeing rats. Appetite. 2012;59 2:478–82. 10.1016/j.appet.2012.05.022 . Grimm JW, North K, Hopkins M, Jiganti K, McCoy A, Sulc J, et al. Sex differences in sucrose reinforcement in Long-Evans rats. Biol Sex Differ. 2022;13 1:3–8. 10.1186/s13293-022-00412-8 . Freeman LR, Bentzley BS, James MH, Aston-Jones G. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. Int J Neuropsychopharmacol. 2021;24 1:54–63. 10.1093/ijnp/pyaa040 . Ousey J, Boktor JC, Mazmanian SK. Gut microbiota suppress feeding induced by palatable foods. Curr Biol. 2023;33. 10.1016/j.cub.2022.10.066 . 1:147,157.e7. Yu KB, Hsiao EY. Roles for the gut microbiota in regulating neuronal feeding circuits. J Clin Invest. 2021;131 10:e143772. 10.1172/JCI143772 . de Wouters d'Oplinter A, Rastelli M, Van Hul M, Delzenne NM, Cani PD, Everard A. Gut microbes participate in food preference alterations during obesity. Gut Microbes. 2021;13(1:1959242). 10.1080/19490976.2021.1959242 . Pinart M, Dotsch A, Schlicht K, Laudes M, Bouwman J, Forslund SK, et al. Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis. Nutrients. 2021;14(1:12). 10.3390/nu14010012 . Borin JM, Liu R, Wang Y, Wu T, Chopyk J, Huang L, et al. Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice. bioRxiv. 2023. 10.1101/2023.02.03.527064 . Leyrolle Q, Cserjesi R, Mulders MDGH, Zamariola G, Hiel S, Gianfrancesco MA, et al. Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients. Clin Nutr. 2021;40 4:2035–44. 10.1016/j.clnu.2020.09.025 . Agusti A, Campillo I, Balzano T, Benitez-Paez A, Lopez-Almela I, Romani-Perez M, et al. Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat. Mol Neurobiol. 2021;58 10:4959–79. 10.1007/s12035-021-02462-2 . Babbs RK, Wojnicki FHE, Corwin RLW. Effect of 2-hydroxyestradiol on binge intake in rats. Physiol Behav. 2011;103 5:508–12. 10.1016/j.physbeh.2011.03.029 . Cason AM, Aston-Jones G. Role of orexin/hypocretin in conditioned sucrose-seeking in rats. Psychopharmacology. 2013;226 1:155–65. 10.1007/s00213-012-2902-y . Cason AM, Aston-Jones G. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist. Psychopharmacology. 2013;228 3:499–507. 10.1007/s00213-013-3051-7 . Bello NT, Yeh C, James MH. Reduced Sensory-Evoked Locus Coeruleus-Norepinephrine Neural Activity in Female Rats With a History of Dietary-Induced Binge Eating. Front Psychol. 2019;10:1966; 10.3389/fpsyg.2019.01966 Krohn TC, Sorensen DB, Otteson JL, Hansen AK. The effects of individual housing on mice and rats: a review. Anim Welf. 2006;15:4. https://doi.org/10.1017/S0962728600030669 . Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79 17:5112–20. 10.1128/AEM.01043-13 . Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37 8:852–7. 10.1038/s41587-019-0209-9 . Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13 7:581–3. 10.1038/nmeth.3869 . Katoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform. 2008;9 4:286–98. 10.1093/bib/bbn013 . Han J, Lin K, Sequeira C, Borchers CH. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2015;854:86–94. 10.1016/j.aca.2014.11.015 . McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8 4:e61217. 10.1371/journal.pone.0061217 . Oksanen J. Vegan: community ecology package. http://CRAN.R-project.org/package=vegan (2010). Liu C, Mansoldo FRP, Li H, Vermelho AB, Zeng RJ, Li X, et al. A workflow for statistical analysis and visualization of microbiome omics data using the R microeco package. Nat Protoc. 2025. 10.1038/s41596-025-01239-4 . Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecology. 2001;26 1; https://doi.org/10.1111/j.1442-9993.2001.01070.pp.x Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol). 1995. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x . 57 1; doi. Ramette A. Multivariate analyses in microbial ecology. FEMS Microbiol Ecol. 2007;62 2:142–60. 10.1111/j.1574-6941.2007.00375.x . Anderson MJ. Distance-based tests for homogeneity of multivariate dispersions. Biometrics. 2006;62 1:245–53. 10.1111/j.1541-0420.2005.00440.x . Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12 6:R60–60. 10.1186/gb-2011-12-6-r60 . Bastian M, Heymann S, Jacomy M. Gephi: An Open Source Software for Exploring and Manipulating Networks. Mar 19 2009:361–2. Stapleton S, Welch G, DiBerardo L, Freeman LR. Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome. Biol Sex Differ. 2024;15 1:5–1. 10.1186/s13293-023-00580-1 . Deshpande NG, Saxena J, Pesaresi TG, Carrell CD, Ashby GB, Liao M, et al. High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats. PLoS ONE. 2019;14 5:e0217553. 10.1371/journal.pone.0217553 . Zimmerman DR. Role of subtherapeutic levels of antimicrobials in pig production. J Anim Sci. 1986;62 3:6–16. Parodi G, Leite G, Pimentel ML, Barlow GM, Fiorentino A, Morales W, et al. The Response of the Rodent Gut Microbiome to Broad-Spectrum Antibiotics Is Different in Males and Females. Front Microbiol. 2022;13:897283. 10.3389/fmicb.2022.897283 . Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond). 2014;38 10:1290–8. 10.1038/ijo.2014.119 . Murphy R, Stewart AW, Braithwaite I, Beasley R, Hancox RJ, Mitchell EA, et al. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int J Obes (Lond). 2014;38 8:1115–9. 10.1038/ijo.2013.218 . Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135 4:617–26. 10.1542/peds.2014-3407 . Bongers KS, McDonald RA, Winner KM, Falkowski NR, Brown CA, Baker JM, et al. Antibiotics cause metabolic changes in mice primarily through microbiome modulation rather than behavioral changes. PLoS ONE. 2022;17 3:e0265023. 10.1371/journal.pone.0265023 . Rosa A, Pinna I, Piras A, Porcedda S, Masala C. Sex Differences in the Bitterness Perception of an Aromatic Myrtle Bitter Liqueur and Bitter Compounds. Nutrients. 2023;15. 10.3390/nu15092030 . 9:2030. Wang J, Liang K, Lin W, Chen C, Jiang R. Influence of age and sex on taste function of healthy subjects. PLoS ONE. 2020;15 6:e0227014. 10.1371/journal.pone.0227014 . Sorokowski P, Karwowski M, Misiak M, Marczak MK, Dziekan M, Hummel T, et al. Sex Differences in Human Olfaction: A Meta-Analysis. Front Psychol. 2019;10:242. 10.3389/fpsyg.2019.00242 . Maheshwar KV, Stuart AE, Kay LM. Sex differences in olfactory behavior and neurophysiology in Long Evans rats. J Neurophysiol. 2025;133 1:257–67. 10.1152/jn.00222.2024 . Kass MD, Czarnecki LA, Moberly AH, McGann JP. Differences in peripheral sensory input to the olfactory bulb between male and female mice. Sci Rep. 2017;7:45851. 10.1038/srep45851 . Jokipii AM, Myllyla VV, Hokkanen E, Jokipii L. Penetration of the blood brain barrier by metronidazole and tinidazole. J Antimicrob Chemother. 1977;3 3:239–45. 10.1093/jac/3.3.239 . Daly CM, Saxena J, Singh J, Bullard MR, Bondy EO, Saxena A, et al. Sex differences in response to a high fat, high sucrose diet in both the gut microbiome and hypothalamic astrocytes and microglia. Nutr Neurosci. 2022;25 2:321–35. 10.1080/1028415X.2020.1752996 . Saxena A, Moran RRM, Bullard MR, Bondy EO, Smith MF, Morris L, et al. Sex differences in the fecal microbiome and hippocampal glial morphology following diet and antibiotic treatment. PLoS ONE. 2022;17(4):e0265850. 10.1371/journal.pone.0265850 . Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, et al. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016;7 4:313–22. 10.1080/19490976.2016.1203502 . Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339 6123:1084–8. 10.1126/science.1233521 . Singh V, Lee G, Son H, Koh H, Kim ES, Unno T, et al. Butyrate producers, The Sentinel of Gut: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol. 2023;13:1103836. 10.3389/fmicb.2022.1103836 . Decsi T, Kennedy K. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr. 2011;94. 10.3945/ajcn.110.000893 . 6 Suppl:1914S–9S. Santosa S, Jensen MD. The Sexual Dimorphism of Lipid Kinetics in Humans. Front Endocrinol (Lausanne). 2015;6:103. 10.3389/fendo.2015.00103 . Tauber JM, Brown EB, Li Y, Yurgel ME, Masek P, Keene AC. A subset of sweet-sensing neurons identified by IR56d are necessary and sufficient for fatty acid taste. PLoS Genet. 2017;13 11:e1007059. 10.1371/journal.pgen.1007059 . Coccurello R, Maccarrone M. Hedonic Eating and the Delicious Circle: From Lipid-Derived Mediators to Brain Dopamine and Back. Front Neurosci. 2018;12:271. 10.3389/fnins.2018.00271 . Woodward ORM, Gribble FM, Reimann F, Lewis JE. Gut peptide regulation of food intake - evidence for the modulation of hedonic feeding. J Physiol. 2022;600 5:1053–78. 10.1113/JP280581 . Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439 7075:484–9. 10.1038/nature04330 . Zaborska KE, Lee SA, Garribay D, Cha E, Cummings BP. Deoxycholic acid supplementation impairs glucose homeostasis in mice. PLoS ONE. 2018;13 7:e0200908. 10.1371/journal.pone.0200908 . Cokorinos EC, Delmore J, Reyes AR, Albuquerque B, Kjobsted R, Jorgensen NO, et al. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. 2017;25 5:11471159e10. 10.1016/j.cmet.2017.04.010 . Qu Q, Chen Y, Wang Y, Long S, Wang W, Yang H, et al. Author Correction: Lithocholic acid phenocopies anti-ageing effects of calorie restriction. Nature. 2025;638 8050:E6–w. 10.1038/s41586-025-08693-w . Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238. 10.1016/j.pharmthera.2022.108238 . Zhang S, Li RJW, Lim Y, Batchuluun B, Liu H, Waise TMZ, et al. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut. 2021;70 9:1675–83. 10.1136/gutjnl-2020-321757 . Waise TMZ, Lim Y, Danaei Z, Zhang S, Lam TKT. Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats. Mol Metab. 2021;44:101132. 10.1016/j.molmet.2020.101132 . Tables Tables 1 to 4 are available in the Supplementary Files section. Additional Declarations No competing interests reported. Supplementary Files FigureS1S3.docx Table14.docx Cite Share Download PDF Status: Under Review Version 1 posted Reviewers invited by journal 01 May, 2026 Editor assigned by journal 01 May, 2026 Submission checks completed at journal 01 May, 2026 First submitted to journal 28 Apr, 2026 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-9557496","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":634536558,"identity":"58566b07-828d-4a2e-a826-2766cf07b75c","order_by":0,"name":"Christopher J. Petty","email":"","orcid":"","institution":"University of Georgia","correspondingAuthor":false,"prefix":"","firstName":"Christopher","middleName":"J.","lastName":"Petty","suffix":""},{"id":634536559,"identity":"5a0af91a-8c86-4a3a-8197-e9a0077ba986","order_by":1,"name":"Mindy Isaman","email":"","orcid":"","institution":"Furman University","correspondingAuthor":false,"prefix":"","firstName":"Mindy","middleName":"","lastName":"Isaman","suffix":""},{"id":634536560,"identity":"8a46221e-ec8a-46df-b1b0-fc5e52f118e2","order_by":2,"name":"Laura Pallas Perez","email":"","orcid":"","institution":"Furman University","correspondingAuthor":false,"prefix":"","firstName":"Laura","middleName":"Pallas","lastName":"Perez","suffix":""},{"id":634536563,"identity":"14f18da1-b2f3-4aac-b86e-243c781b64ae","order_by":3,"name":"Sophie Millard","email":"","orcid":"","institution":"Clemson University","correspondingAuthor":false,"prefix":"","firstName":"Sophie","middleName":"","lastName":"Millard","suffix":""},{"id":634536565,"identity":"241ff773-e851-46e0-a91d-558757218a6e","order_by":4,"name":"Max Ortiz","email":"","orcid":"","institution":"Clemson University","correspondingAuthor":false,"prefix":"","firstName":"Max","middleName":"","lastName":"Ortiz","suffix":""},{"id":634536567,"identity":"90551963-f0ae-46bc-b122-b57effd1a390","order_by":5,"name":"Linnea R. Freeman","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA+0lEQVRIiWNgGAWjYBACPmYIzQ/l28AYDIwNOLSwQbVIQhWkwRh4tDCgajlMhBZ23mMPPtQwSJi3Nx/d8HPHeQmD26cTPxcw2MhuOIDLYXzphjOOMUjInDmWdrP3zG0Jg3O5m6VnMKQZ49bCYybNw8ZQJyGRY3aDt+12ncEZ3g3SPAyHE/Fq+fOPQUJC/v23m3/bzkkAtWz+zcPwH78WxjagFgkettu8bQdAWrYBbTmAV4tkbx9IR5rZbdm2ZAlJoBZrHoNk45k4tPDznzGT+PHNRkKC/fCzm2/b7CT4gA67zVNhJ9uHQwsUSKALGOBVPgpGwSgYBaOAAAAA4XBTafrk/9UAAAAASUVORK5CYII=","orcid":"","institution":"Furman University","correspondingAuthor":true,"prefix":"","firstName":"Linnea","middleName":"R.","lastName":"Freeman","suffix":""}],"badges":[],"createdAt":"2026-04-28 18:38:16","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-9557496/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-9557496/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":108985577,"identity":"c6cc94f7-bb92-4b7b-b7c1-0d9ab427dd04","added_by":"auto","created_at":"2026-05-11 12:47:44","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":175422,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eAnimal Measurements.\u003c/strong\u003e Body weights, food consumption, and water intake were monitored weekly during the study. \u003cstrong\u003eA)\u003c/strong\u003e Pre-treatment, Male Control gained significantly more weight than Female Control (\u003cem\u003ep\u003c/em\u003e \u0026lt;0.0001) and Female Antibiotics (\u003cem\u003ep\u003c/em\u003e= 0.0048). Male Antibiotics also gained significantly more weight than Female Control (\u003cem\u003ep\u003c/em\u003e = 0.0128). There were no statistically significant differences in body weight gain post-treatment. \u003cstrong\u003eB)\u003c/strong\u003e There was a significant sex x treatment effect (F(3,27) = 6.649, \u003cem\u003ep\u003c/em\u003e = 0.0017), time effect (F(1,27) = 80.27, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.0001), and sex x treatment x time interaction effect (F(3,27) = 7.165, \u003cem\u003ep\u003c/em\u003e = 0.0011) for food consumption. \u003cstrong\u003eC)\u003c/strong\u003eThere was a significant sex x treatment effect for water consumption (F(3,27) = 7.677, \u003cem\u003ep\u003c/em\u003e = 0.0007) and a sex x treatment x time interaction effect (F(3,25) = 4.813, \u003cem\u003ep\u003c/em\u003e = 0.0088).\u003c/p\u003e","description":"","filename":"Picture1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/8665e3642a3fdbf7c5614059.jpg"},{"id":108985534,"identity":"ee8bb08b-59a4-42fc-9824-7abd2d868e0d","added_by":"auto","created_at":"2026-05-11 12:47:03","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":244818,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eBehavioral Economics and Estrus Cycle Analysis.\u003c/strong\u003e \u003cstrong\u003eA)\u003c/strong\u003e A significant sex x treatment effect was determined for Q\u003csub\u003e0\u003c/sub\u003e values (F(3, 28) = 6.477; \u003cem\u003ep\u003c/em\u003e = 0.0018).\u0026nbsp; Q\u003csub\u003e0\u003c/sub\u003e values were significantly higher (\u003cem\u003ep\u003c/em\u003e = 0.0119) for Female Control compared to Male Control. Female Antibiotics Q\u003csub\u003e0\u003c/sub\u003e was also significantly higher than Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0016). There was no statistically significant difference between Male Antibiotics and Female Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0627). \u003cstrong\u003eB)\u003c/strong\u003e Q\u003csub\u003e0\u003c/sub\u003e values pre-treatment and post-treatment, with the estrus cycle characterized for that final day of BE testing when the female had a stable α value. There are not enough data points to conduct statistical tests on these data. \u003cstrong\u003eC)\u003c/strong\u003e No statistically significant sex or treatment differences were determined for α at any stage of the experiment.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","description":"","filename":"Picture2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/007f92d4fa15c2c0fb29e311.jpg"},{"id":108985535,"identity":"ec34fd52-8018-472d-9a14-10cc43ae526f","added_by":"auto","created_at":"2026-05-11 12:47:04","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":445189,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eAlteration of the rat fecal microbiome composition following antibiotic treatment\u003c/strong\u003e. \u003cstrong\u003eA) \u003c/strong\u003eLog\u003csub\u003e10 \u003c/sub\u003emean relative abundance of the 40 most abundant bacterial genera across experimental groups. \u003cstrong\u003eB) \u003c/strong\u003eThe 20\u003csub\u003e \u003c/sub\u003egenera with the largest differences in relative abundance (LDA \u0026gt; 3.5, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.05) between pre- and post-antibiotic\u003csub\u003e \u003c/sub\u003etreatment, as identified by Linear Discriminant Analysis Effect Size (LEfSe). Significance between\u003csub\u003e \u003c/sub\u003epre- and post-antibiotic treatment was determined using the Wilcoxon rank-sum test (*\u003cem\u003ep\u003c/em\u003e \u0026lt; 0.01, **\u003cem\u003ep\u003c/em\u003e \u0026lt;0.001, ***\u003cem\u003ep\u003c/em\u003e \u0026lt; 0.0001).\u003c/p\u003e","description":"","filename":"Picture3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/d20d7a6395c40795c490fa70.jpg"},{"id":108985542,"identity":"e56c53ad-b77b-40e7-987a-4ef430c03344","added_by":"auto","created_at":"2026-05-11 12:47:07","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":263096,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eAntibiotic treatment alters the community structure of the rat fecal microbiome. A) \u003c/strong\u003ePrincipal Coordinate Analysis (PCoA) of fecal microbiota\u003cstrong\u003e \u003c/strong\u003efrom rats pre-treatment or post-water or antibiotic treatment, based on weighted\u003cstrong\u003e \u003c/strong\u003eUniFrac distances of Amplicon Sequence Variant (ASV) abundances\u003cstrong\u003e \u003c/strong\u003e(PERMANOVA, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.001). \u003cstrong\u003eB) \u003c/strong\u003eShannon diversity index and \u003cstrong\u003eC) \u003c/strong\u003eInverse Simpson\u003cstrong\u003e \u003c/strong\u003ediversity index calculated from rat fecal samples. Statistical significance\u003cstrong\u003e \u003c/strong\u003ebetween groups was assessed using the Wilcoxon rank-sum test (*\u003cem\u003ep\u003c/em\u003e \u0026lt; 0.01).\u003c/p\u003e","description":"","filename":"Picture4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/a81b936f177817b540d68bb4.jpg"},{"id":108985652,"identity":"a7dd5610-a54c-420b-b7ed-f344474ffe45","added_by":"auto","created_at":"2026-05-11 12:48:18","extension":"jpg","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":419350,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eImpact of hedonic feeding and related variables on the gut microbiome.\u003c/strong\u003e \u003cstrong\u003eA)\u003c/strong\u003e Correlation analysis between SCFA content, food and water consumption, sex, and microbial genera. Pearson correlation coefficients were calculated, and only taxa with \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.001 are shown. \u003cstrong\u003eB) \u003c/strong\u003eRedundancy analysis (RDA) plot illustrating the relationships between microbial community structure and three SCFAs identified as significant drivers.\u003c/p\u003e","description":"","filename":"Picture5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/efba08ad84f69cb184376f4f.jpg"},{"id":108986883,"identity":"73f6334b-f85f-4660-bf9c-07a7483bf9d6","added_by":"auto","created_at":"2026-05-11 12:56:46","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1911778,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/faaa75fa-cd61-4f34-be28-58b445eaf3cc.pdf"},{"id":108985515,"identity":"827bafa6-a0b3-438f-b621-1c273cda8bf3","added_by":"auto","created_at":"2026-05-11 12:46:54","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1068624,"visible":true,"origin":"","legend":"","description":"","filename":"FigureS1S3.docx","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/3141cc8d251fbb8acbaba900.docx"},{"id":108985493,"identity":"fffc0226-0e6b-44a4-91ba-9765d0b92f3a","added_by":"auto","created_at":"2026-05-11 12:46:54","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":31905,"visible":true,"origin":"","legend":"","description":"","filename":"Table14.docx","url":"https://assets-eu.researchsquare.com/files/rs-9557496/v1/6395da349977ec538e29e7f2.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Sex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption","fulltext":[{"header":"Plain English summary","content":"\u003cp\u003eObesity incidence has continued to rise in the United States as well as the world. The prevalence of obesity affects more women than men, especially severe obesity. Some of the proposed causes of obesity/severe obesity are increased access to calorie-dense foods, decreased energy expenditure, and increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor as the widespread availability of palatable foods can lead to chronic overconsumption. We evaluated hedonic feeding using a behavioral economics approach in male and female rats. We also characterized the fecal microbiome and multiple metabolites related to the gut microbiome. This study aimed to evaluate the role of the gut microbiome in sex differences in hedonic feeding. We determined that female rats consume more of the high fat, high sugar reward compared to males under no-cost conditions of the behavioral economics paradigm. However, we did not determine significant differences in the composition of the gut microbiome at the genus level that could explain the sex differences in hedonic feeding. Lastly, we characterized sex differences in the bacterial composition of the fecal microbiome, fecal and serum short chain fatty acid, and serum bile acid composition following antibiotic treatment. More research will be necessary for network factors such as microbiome \u0026ndash; bile acid effects on feeding that exhibit sex differences.\u003c/p\u003e"},{"header":"Background","content":"\u003cp\u003eObesity (body mass index\u0026thinsp;\u0026ge;\u0026thinsp;30) and severe obesity (body mass index\u0026thinsp;\u0026ge;\u0026thinsp;40) prevalence in the United States have increased between 2000 and 2023 from 30.5% to 40.3% and 4.7% to 9.4%, respectively (CDC). Specifically, the prevalence of obesity for adult women in 2000 was 33.4% compared to 27.5% for adult men. In 2023, the prevalence of obesity for adult women was 41.3% compared to 39.2% for adult men. The prevalence of severe obesity for adult women in the United States was 6.2% in 2000 compared to 3.1% for adult men; it was 12.1% for adult women in 2023 compared to 6.7% for adult men [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Sex differences in obesity prevalence have decreased as obesity rates have risen, but the sex differences in severe obesity remain. Among the proposed causes of obesity/severe obesity are increased access to calorie-dense foods, decreased energy expenditure, and increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor as the combination of food-driven reward seeking and widespread availability of palatable foods can lead to chronic overconsumption.\u003c/p\u003e \u003cp\u003eSex differences in palatable food consumption have been determined in preclinical studies. Female rats consume more palatable food and escalate their intake faster compared to males [\u003cspan additionalcitationids=\"CR5 CR6\" citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. We have previously shown that females have a higher demand at null cost for three different palatable rewards using a behavioral economics (BE) single-session paradigm, a de-escalating fixed ratio operant task designed to evaluate a reward\u0026rsquo;s value and measure how much effort the subject is willing to expend to earn that reward [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. These sex differences in hedonic feeding could provide support for observed sex differences in severe obesity.\u003c/p\u003e \u003cp\u003eOne factor that impacts feeding behavior is the gut microbiome composition [\u003cspan additionalcitationids=\"CR10\" citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. Germ-free mice consume more sucrose compared to controls when administered a high concentration of sucrose solution. Male mice given antibiotics to deplete their gut microbiome have been shown to consume more sucrose pellets compared to vehicle controls. Furthermore, antibiotic-treated mice that received fecal transplants from specific pathogen-free donors reduced sucrose pellet consumption, comparable to vehicle controls [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. These findings suggest that the microbiome plays a role in reward-driven feeding. Studies have also shown that individuals with obesity exhibit an altered gut microbiome [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. This difference in the microbiome has been studied in animal models as well, revealing that a fecal microbiota transplant from obese to germ-free mice leads to weight gain in the mice that received the obese microbiota profile [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e, \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eHere, we used a novel, behavioral economics approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet before and after antibiotic administration. This behavior analysis focused on hedonic feeding behavior; animals were not obese. Specifically, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q\u003csub\u003e0\u003c/sub\u003e), a prediction of consumption at null effort extrapolated from the animals\u0026rsquo; consumption at low price. We determined a higher demand at null cost for the HFP reward pellet for females compared to males, as we have observed previously [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. Furthermore, we investigated hedonic feeding behavior before and after antibiotic administration; an antibiotic cocktail was administered in the drinking water for one month in order to disrupt the gut microbiome. We analyzed hedonic feeding behavior, homecage chow consumption, body weights, fecal microbiome composition and diversity, fecal and serum short chain fatty acid composition, and serum bile acid composition. While demand at null cost (Q\u003csub\u003e0\u003c/sub\u003e) values were significantly different between Male Control and Female Control as well as Male Control and Female Antibiotics pre-treatment, we did not determine a statistically significant difference between any of the groups post-treatment. Overall, there was no sex difference in hedonic feeding in post-treatment groups and antibiotics did not have a statistically significant effect on hedonic feeding; however, antibiotics did alter the fecal microbiome and decreased fecal SCFA, serum SCFA, and serum bile acid composition.\u003c/p\u003e "},{"header":"Methods","content":"\u003cp\u003eAnimals\u003c/p\u003e \u003cp\u003eMale and female Sprague Dawley rats (Charles River Laboratories; n\u0026thinsp;=\u0026thinsp;45) were individually housed and kept on a reverse 12-hour-light schedule, with behavior experiments occurring during the dark cycle. In order to monitor food consumption, water intake, and the fecal microbiome, rats were housed individually, as done previously in other dietary studies [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e, \u003cspan additionalcitationids=\"CR17 CR18\" citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]. Despite single housing, rats were housed in the same room to expose them to olfactory, visual, and auditory stimuli produced by other subjects and were therefore not completely isolated [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e]. Rats were frequently handled due to daily training or testing throughout the study. Rats had ad libitum access to chow (PicoLab \u0026reg; Laboratory Rodent Diet 5L0D, irradiated, Lab Supply, Northlake, TX), consisting of 13% calories from fat, 58% from carbohydrates, and 29% from protein, and water throughout the duration of the experiment outside of the antibiotic phase where water was substituted with an antibiotic cocktail for a subgroup of rats. Body weights, food consumption, and water intake were monitored weekly throughout the study. Body weights were also monitored daily during BE testing phases; we normalize Q\u003csub\u003e0\u003c/sub\u003e values to body weight so we needed daily measurements for those calculations. All protocols and procedures followed the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the Furman University Institutional Animal Care and Use Committee.\u003c/p\u003e \u003cp\u003eReward Pellet\u003c/p\u003e \u003cp\u003eDuring BE training and testing, a high-fat palatable (HFP) 45 mg pellet (Bio-Serv, Frenchtown, NJ) was utilized (0.72 kcal/g protein, 2.11 kcal/g fat, 1.77 kcal/g carbohydrate; Product #F06162). Hydrogenated cottonseed oil and soybean oil constitute the fat sources in this food reward. This pellet also contains dextrose and sucrose contributing to the palatability. In addition to the nutrients mentioned above, the pellet contains a standard mineral and vitamin mix.\u003c/p\u003e \u003cp\u003eStudy Design\u003c/p\u003e \u003cp\u003eRats were trained to press an active lever for the HFP pellet in an operant chamber (Med Associates) housed inside a sound-attenuating cubicle. The cubicle contained a red house light, two retractable levers with white cue lights above them, a food hopper, and a tone generator to reinforce the pressing of the active lever inside the chamber. Rats were trained on fixed ratio 1 (FR1) training followed by FR3, FR10, FR32, and FR100, each for a minimum of 2 days, during which they had to meet criteria for at least 50 lever presses (except FR100, which did not have a minimum lever press criteria and was only administered one day to avoid extinction). Animals not progressing through the fixed ratio training were removed from the study (n\u0026thinsp;=\u0026thinsp;11 males and n\u0026thinsp;=\u0026thinsp;2 females). After one day of FR100 training, rats started the BE testing. During the 105-minute BE session, a 5-minute \"active period\" was signaled by the house light's illumination and the levers' extension. During the active periods, responses to the active lever delivered the reward pellets on an FR schedule. The first active period was the highest schedule of reinforcement at FR100, followed by FR32, FR10, FR3, and finally, FR1. There was no maximum for pellets earned during testing. Instead, 20-minute time-out periods signaled darkness in the chamber and retraction of the levers; the time-out and the reverse order of FR schedules were employed to limit satiation. Responses on an inactive lever were not reinforced. This design produced full demand curves. Rats were administered at least 6 BE sessions until α (demand elasticity) varied less than 25% across the last three days. While this novel, behavioral economics approach includes all FR values during a single session, multiple testing sessions allow for assessment of consistent behavior, providing a \u0026ldquo;stable\u0026rdquo; α value and the associated Q\u003csub\u003e0\u003c/sub\u003e value for that session. Once the rats reached a stable baseline α, they were treated with an antibiotic cocktail containing 0.5g/L of vancomycin, 1.0g/L ampicillin, and 1.0g/L neomycin added to the homecage drinking water (Cayman Chemical Company, Ann Harbor, MI). Antibiotic water was monitored and changed twice weekly.\u003c/p\u003e \u003cp\u003eAfter one month of antibiotic treatment, the rats completed a second round of BE testing, following the abovementioned protocol. The antibiotic water also continued during this second round of BE testing. A control group received normal drinking water for one month and then completed BE testing, still receiving normal drinking water. After completion of the protocol, rats were euthanized and trunk blood was collected.\u003c/p\u003e \u003cp\u003eFecal Microbiome Analysis\u003c/p\u003e \u003cp\u003eFecal samples were collected via sterile technique on days 5 and 6 of the initial BE testing as well as on days 5 and 6 of the second BE testing. Samples were sent to Clemson University Genomics and Bioinformatics Facility (CUGBF) for extraction, library preparation, and sequencing. DNA was extracted from fecal pellets with the DNeasy UltraClean Microbial kit (Qiagen, #1224-50). Library preparation and 16S rRNA gene amplicon sequencing was conducted following the protocol developed by Kozich et al. [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. Briefly, the V3-V4 region of the 16S rRNA gene was PCR-amplified using barcoded dual-index primers. Upon confirmation of a correctly sized PCR product using gel electrophoresis (Invitrogen, #G401002), PCR products were normalized using the SequelPrep plate kit (Life Technologies, #A10510-01) and pooled per 96-well plate. Each pool was quantified using qPCR (KapaBiosystems, #KK4854) and sized using the Agilent Bioanalyzer high-sensitivity DNA kit (Agilent, #5067\u0026thinsp;\u0026minus;\u0026thinsp;4642). Multiplexed pooled amplicon libraries were sequenced paired end 2 x 300 cycles on the Illumina NextSeq2000 platform with a 10% PhiX spike according to manufacturer\u0026rsquo;s protocol.\u003c/p\u003e \u003cp\u003eInitial amplicon sequence processing was conducted in QIIME2 v.2024.2 [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Raw sequences were quality filtered, denoised, and assigned to Amplicon Sequence Variants (ASVs) using the DADA2 plugin [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. Representative sequences were aligned using a multiple sequence alignment program (MAFFT) and a phylogenetic tree was generated with fasttree [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e]. ASVs taxonomy were assigned using the SILVA 138 database. The final ASVs table was rarefied to 25.9k reads per sample and used for subsequent analyses.\u003c/p\u003e \u003cp\u003eShort Chain Fatty Acid (SCFA) and Bile Acid Analysis\u003c/p\u003e \u003cp\u003eThe Duke Proteomics and Metabolomics Core Facility performed SCFA and bile acid analysis. Each fecal sample (50\u0026ndash;100 mg) was placed in bead blaster CK-14 homogenization tubes (Bertin Corp) and homogenized using the Precellys 24 bead blaster (Bertin Instruments) at 4\u0026deg;C for three cycles of 10 seconds each at 10,000 rpm, with a 60-second pause between bursts. After homogenization, sample extracts underwent centrifugation at 15,000 relative centrifugal force for 15 minutes at 4\u0026deg;C. Data collection utilized LC\u0026ndash;MS/MS on a Waters Xevo TQ-S mass spectrometer. Calibration curves were established for each analyte, and a \u003csup\u003e13\u003c/sup\u003eC\u003csub\u003e6\u003c/sub\u003e internal standard was used for compound quantification (via \u003csup\u003e13\u003c/sup\u003eC\u003csub\u003e6\u003c/sub\u003e NPH derivatization reagent). Data analysis was performed using Skyline software (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e\u003ca href=\"http://www.skyline.ms\" target=\"_blank\"\u003ewww.skyline.ms\u003c/a\u003e\u003c/span\u003e\u003cspan address=\"http://www.skyline.ms\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e), with initial concentrations reported in \u0026micro;M. To convert concentrations, the mass of feces homogenized and extracted was included, along with the volume of solvent added, resulting in nmol/mg concentrations.\u003c/p\u003e \u003cp\u003eSerum samples were also analyzed for SCFAs. This analysis was performed with the Sciex QTrap 6500\u0026thinsp;+\u0026thinsp;system (Framingham, MA) with Waters Acquity I-class plus UPLC. Software Analyst 1.7.3 was used for data acquisition. For sample preparation, 20 \u0026micro;L serum was mixed with 40\u0026micro;L ethanol, and then kept at -20\u003csup\u003eo\u003c/sup\u003e C for 20 min, followed by vortex and then centrifugation at 15,000 rcf for 4 minutes at 10\u003csup\u003eo\u003c/sup\u003e C. All data was analyzed in Skyline v23.1.0.455 (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e\u003ca href=\"http://www.skyline.ms\" target=\"_blank\"\u003ewww.skyline.ms\u003c/a\u003e\u003c/span\u003e\u003cspan address=\"http://www.skyline.ms\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e) which includes raw data import, peak integration, and a quadratic regression fit with 1/x2 weighting for the calibration curves for SCFA. The SCFA method quantified 12 SCFAs commonly found in biological samples: acetic acid, propionic acid, iso-butyric acid, butyric acid, 2-methyl butyric acid, iso-valeric acid, valeric acid, 3-methyl valeric acid, iso-caproic acid, caproic acid, heptanoic acid, and octanoic acid. This validated method is based on previous work published by Han et al. [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eSerum samples were analyzed with the Biocrates Bile Acids assay (Biocrates, Innsbruck, Austria), which quantifies 20 bile acids. The serum samples were centrifuged at 10,000 rcf for 2 minutes in a refrigerated (4\u0026deg;C) centrifuge then stored on ice until addition to the bile acids kit plate. Samples were prepared in strict accordance with the Biocrates detailed protocol. Addition of 10 \u0026micro;L of the supplied internal standard solution to each well of the 96-well extraction plate was followed by drying under a gentle stream of nitrogen. Study samples, calibration standards, and QCs were added in 10 \u0026micro;L aliquots to the appropriate wells. The plate was then dried a second time under a gentle stream of nitrogen. The samples were eluted with methanol then diluted with water. Sample analysis of bile acids was performed by a Waters ultra-high pressure liquid chromatography (UPLC) tandem mass spectrometric method using a reversed phase analytical column for analyte separation. Selective analyte detection was accomplished by use of a Xevo TQ-S triple quadrupole tandem mass spectrometer operated in multiple Reaction Monitoring (MRM) mode, in which specific precursor to product ion transitions were measured for every analyte and stable isotope labeled internal standard. Pools of the study samples (SPQC) were injected before, during, and after the study samples in order to measure the performance of the assay across the sample cohort. The UPLC-MS/MS data were directly imported into Biocrates WebIDQ\u0026trade; software for peak integration, calibration, and concentration calculations.\u003c/p\u003e \u003cp\u003eEstrus Cycle Analysis\u003c/p\u003e \u003cp\u003eDuring BE testing, the estrus cycle was evaluated via vaginal lavage. Female rats were acclimated to the action of a vaginal lavage beginning on the first day of FR32 training through the action of handling and imitation of the lavage with an empty and sterile transfer pipette. Therefore, females were acclimated to vaginal lavage prior to BE testing. When the rats entered the testing phase, researchers collected cell samples via vaginal lavage using a 0.9% NaCl solution until stabilization on the BE task occurred. Collected samples were smeared onto a glass slide, stained with Quik-Dip Hematology Stain (Mercedes Medical, FL) and evaluated under the microscope in order to characterize the cycle phase (estrus, proestrus, diestrus, and metestrus). The cycle phase during the test day that a stable α value was reached is shown in Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003eB.\u003c/p\u003e \u003cdiv id=\"Sec2\" class=\"Section2\"\u003e \u003ch2\u003eStatistical Analysis\u003c/h2\u003e \u003cp\u003eStatistical tests were completed using GraphPad Prism (GraphPad Software, La Jolla, California, USA, \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e\u003ca href=\"http://www.skyline.ms\" target=\"_blank\"\u003ewww.graphpad.com\u003c/a\u003e\u003c/span\u003e\u003cspan address=\"http://www.graphpad.com\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e) and R v.4.4.1. Body weight gain, food consumption, water consumption, BE values, and fecal SCFAs were analyzed using a linear mixed-effects model with Time (pre vs post), Sex, and Treatment as fixed effects and animal ID as a random effect. Tukey\u0026rsquo;s multiple comparisons test was conducted to correct for multiple testing. Serum bile acids and SCFAs were analyzed using a one-way ANOVA since serum was only collected at the end of the study; a pre vs post analysis was not conducted.\u003c/p\u003e \u003cp\u003eMicrobiome diversity analyses were performed in R v.4.4.1 using phyloseq [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e], vegan [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e] and microeco packages [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. In alpha-diversity, the Kruskal\u0026ndash;Wallis rank-sum test was subsequently used to calculate the significance of mean differences in variables between treatments, and the pairwise Wilcoxon rank-sum test was used to compare significant differences between groups [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. P-value correction for multiple testing was performed according to the Benjamini-Hochberg FDR method [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. Beta diversity was assessed using Principal Coordinates Analysis (PCoA) [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e] based on Bray\u0026ndash;Curtis and Weighted Unifrac distance matrices. Permutational Multivariate Analyses of Variance (PERMANOVA), with 999 permutations, was used to test for significant differences between groups [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. Variations within communities were determined by distance-based tests for homogeneity using the betadisper function [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e]. Differential abundant taxa were determined using LEfSe (Linear discriminant analysis Effect Size) [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]. Co-occurrence networks at genera level were constructed for water- and antibiotic-treated groups. ASVs with low relative abundance were removed and Spearman correlations were calculated with Benjamini-Hochberg FDR P value correction [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. Only significant relationships with a correlation coefficient (ρ)\u0026thinsp;\u0026ge;\u0026thinsp;\u0026plusmn;\u0026thinsp;0.6 and P\u0026thinsp;\u0026lt;\u0026thinsp;0.01 were selected and translated into networks. The networks were further visualized using the interactive platform Gephi v.0.10.1 [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e].\u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cp\u003eThe percentage of body weight gain (change in weight divided by starting weight), from the start of the experiment to the end of the first session of BE testing (Pre-Treatment), and then the end of the first session of BE testing to the end of the second session of BE testing (Post-Treatment), was compared between four groups: Male Control, Male Antibiotics, Female Control, Female Antibiotics (Figure 1A). A significant sex x treatment effect was determined (F(3,56) = 10.78, \u003cem\u003ep\u003c/em\u003e \u0026lt;0.0001). Pre-treatment, Male Control gained significantly more weight than Female Control (\u003cem\u003ep\u003c/em\u003e \u0026lt;0.0001) and Female Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0048). Male Antibiotics also gained significantly more weight than Female Control (\u003cem\u003ep\u003c/em\u003e = 0.0128). These changes in body weight were prior to antibiotic treatment, or control, water treatment; this confirms no statistically significant differences for Male Control vs. Male Antibiotics and Female Control vs. Female Antibiotics at baseline. There were no statistically significant differences in body weight gain post-treatment. Homecage chow consumption (Figure 1B) and water consumption (Figure 1C) were evaluated weekly throughout the study. Average food consumption and water consumption, pre-treatment and post-treatment, were normalized to the animal\u0026rsquo;s body weight. There was a significant sex x treatment effect (F(3,27) = 6.649, \u003cem\u003ep\u003c/em\u003e = 0.0017), time effect (F(1,27) = 80.27, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.0001), and sex x treatment x time interaction effect (F(3,27) = 7.165, \u003cem\u003ep\u003c/em\u003e = 0.0011) for food consumption. Female Control consumed significantly more homecage food (normalized to body weight) compared to Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0492) and Male Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0389), pre-treatment. Female Antibiotics consumed significantly more homecage food compared to Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0074) and Male Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0052), pre-treatment. Given that these were baseline, pre-treatment measurements, no statistically significant differences between Male Control and Male Antibiotics or Female Control and Female Antibiotics were observed, as expected. Post-treatment, Female Control continued to consume more homecage food compared to Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0169) and Male Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0004). Post-treatment, Female Antibiotics consumed less homecage food, but this was not significantly different from Female Control (\u003cem\u003ep\u003c/em\u003e = 0.3394). \u0026nbsp;There was a significant sex x treatment effect for water consumption (F(3,27) = 7.677, \u003cem\u003ep\u0026nbsp;\u003c/em\u003e= 0.0007) and a sex x treatment x time interaction effect (F(3,25) = 4.813, \u003cem\u003ep\u003c/em\u003e = 0.0088). Pre-treatment, Female Antibiotics consumed significantly more water than Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0411). Post-treatment, Female Antibiotics drank more water compared to all other groups:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eFemale Antibiotics vs. Male Control: \u003cem\u003ep\u003c/em\u003e\u0026lt; 0.0001, Female Antibiotics vs. Male Antibiotics: \u003cem\u003ep\u003c/em\u003e\u0026lt; 0.0001, and Female Antibiotics vs. Female Control: \u003cem\u003ep\u003c/em\u003e = 0.0052. Given that females drank the most antibiotic water, they did receive a higher dose of antibiotics compared to males (\u003cem\u003ep\u003c/em\u003e\u0026lt;0.0001).\u003c/p\u003e\n\u003cp\u003eA significant sex x treatment effect was determined for Q\u003csub\u003e0\u0026nbsp;\u003c/sub\u003evalues (F(3, 28) = 6.477; \u003cem\u003ep\u003c/em\u003e = 0.0018). \u0026nbsp;Q\u003csub\u003e0\u003c/sub\u003e values were significantly higher (\u003cem\u003ep\u003c/em\u003e = 0.0119) for Female Control compared to Male Control (Figure 2A). Female Antibiotics Q\u003csub\u003e0\u003c/sub\u003e was also significantly higher than Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0016). There was no statistically significant difference between Male Antibiotics and Female Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.0627). There was also no statistically significant difference for Male Control vs. Male Antibiotics (\u003cem\u003ep\u003c/em\u003e = 0.5019) or Female Control vs. Female Antibiotics (p = 0.2747). If pre-treatment groups are collapsed and compared by sex: female pre-treatment has significantly higher Q\u003csub\u003e0\u003c/sub\u003e values compared to male pre-treatment (\u003cem\u003ep\u003c/em\u003e = 0.0110) as determined by Welch\u0026rsquo;s t-test. Q\u003csub\u003e0\u003c/sub\u003e individual values pre- vs. post-treatment are further compared in Figure S1. No statistically significant differences in values pre- vs. post-treatment were determined with a paired t-test within each sex and treatment group. The estrus cycle was characterized after collection of samples via vaginal lavage throughout BE testing. Female rats stabilized on the BE paradigm during the four stages of their cycle: diestrus, proestrus, estrus, and metestrus. Figure 2B displays the Q\u003csub\u003e0\u003c/sub\u003e values pre-treatment and post-treatment, with the estrus cycle characterized for that final day of BE testing when the female had a stable \u0026alpha; value. There are not enough data points to conduct statistical tests on these data. No statistically significant sex or treatment differences were determined for \u0026alpha; at any stage of the experiment (Figure 2C). Table 1 displays the average number of active and inactive lever presses as well as pellets earned for males and females during the training period, prior to the BE testing.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 1. Average Number of Active/Inactive Lever Responses and Pellets Earned During 1-Hour FR Training Sessions Prior to BE Testing.\u003c/strong\u003e Values are n (SEM).\u003c/p\u003e\n\u003cp\u003eThe composition of the fecal microbiome was altered by antibiotics. Many of the top 40 most abundant genera showed significantly decreased relative abundance following administration of the antibiotic cocktail in both male and female rats (Figure 3A). Post-antibiotics, males had increased relative abundance of \u003cem\u003eClostridia vadin BB60\u0026nbsp;\u003c/em\u003eand\u003cem\u003e\u0026nbsp;Morganellaceae\u0026nbsp;\u003c/em\u003ecompared to pre- treatment and water groups. Although not statistically significant, these genera appeared to be \u0026nbsp;higher in abundance in males post-antibiotics compared to females post-antibiotics. Conversely, females showed increased relative abundance of \u003cem\u003eBacillaceae, Nocardiopsaceae, Brevibacillaceae, and Paenibacillaceae\u0026nbsp;\u003c/em\u003ecompared to pre-treatment and water groups. Once again, no statistical significance in the abundance of these genera was found between sexes after antibiotic treatment although their abundance does appear to be higher in females compared to males post-antibiotics. Linear Discriminant Analysis Effect Size (LEfSe) was used to compare the relative abundance of the top 20 genera between rats pre-and post-antibiotics (Figure 3B). Consistent with the heatmap findings, the genera showing the most significant differences in relative abundance (LDA \u0026gt; 3.5, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.05) included \u003cem\u003eLactobacillus\u003c/em\u003e, \u003cem\u003eMuribaculaceae\u003c/em\u003e, and \u003cem\u003eRomboutsia\u003c/em\u003e, which decreased following antibiotic treatment, and \u003cem\u003eEscherichia\u0026ndash;Shigella\u003c/em\u003e and \u003cem\u003eEnterococcus\u003c/em\u003e, which increased (Figure 3B). Several of these genera were also identified in genus-level co-occurrence networks, revealing patterns of positive associations among taxa in control (Figure S2A) and antibiotic-treated (Figure S2B) rats.\u003c/p\u003e\n\u003cp\u003eAs shown by the Principal Coordinate Analysis (PCoA) plot, a significant shift in the structure of the fecal microbiome occurred due to antibiotic treatment (PERMANOVA, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.01; Figure 4A). Pre-control and pre-antibiotics samples compared to post-antibiotics revealed a statistically significant difference (\u003cem\u003ep\u003c/em\u003e = 0.001), pre-control samples compared to post-control did not reveal a statistically significant difference (\u003cem\u003ep\u003c/em\u003e = 0.63; Figure 4A). Additionally, there was a significant decrease in microbiome diversity after antibiotic treatment (Wilcoxon rank-sum test, \u003cem\u003ep\u003c/em\u003e \u0026lt; 0.01) as addressed by Shannon (Figure 4B) and Inverse Simpson (Figure 4C) diversity metrics. Among post-antibiotic treated rats, there was no statistically significant difference in microbiome structure between males and females as shown by the PCoA plot (Figure S3A). For the Shannon diversity index (Figure S3B), both males and females revealed a significant decrease for post-antibiotics samples compared to post-control. Females also displayed a significant decrease for pre-antibiotics compared to post-control. For the Inverse Simpson diversity index (Figure S3C), no statistically significant difference was determined for males. Females had a decreased Inverse Simpson diversity index for post-antibiotics compared to post-control.\u003c/p\u003e\n\u003cp\u003eShort chain fatty acid (SCFA) analysis in serum as well as fecal samples further revealed the effects of antibiotic treatment on the gut microbiome. All SCFAs were decreased following antibiotic treatment in both sexes. For example, the mean fecal acetic acid level for the Male Antibiotics group was 53.83 nmol/mg pre-treatment and 6.37 nmol/mg post-treatment. The mean fecal acetic acid level for the Female Antibiotics group was 59.01 nmol/mg pre-treatment and 0.99 nmol/mg post-treatment. Table 2 displays those differences in fecal SCFAs (# indicates a trend, \u003cem\u003ep\u003c/em\u003e-values are reported); the top of the table includes mean values for fecal SCFAs (nmol/mg) by group, from samples collected prior to the antibiotic or control (water) administration. Below, are the mean fecal SCFA values (nmol/mg) by group, post-treatment, followed by statistical comparisons for the post-treatment values. No significant differences were determined for pre-treatment values. Finally, the bottom of the table includes pre vs. post-treatment statistical comparisons. Table 3 displays serum SCFA values (\u0026micro;M) and statistical comparisons. Serum was only collected at the end of the study. Therefore, we do not have pre vs. post-treatment comparisons, only serum SCFA comparisons by group. Three serum SCFA levels were below detection for antibiotics-treated groups: propionic acid, butyric acid, and valeric acid. Interestingly, some serum SCFAs were not significantly changed by antibiotic treatment. For example, iso-butyric acid levels were slightly increased (not statistically significant) for antibiotics-treated groups compared to control (water) groups, in both sexes. Importantly, we also observed a sex difference in serum iso-caproic acid in water groups as well as a sex difference in serum octanoic acid in antibiotics groups. Females had higher levels of iso-caproic acid compared to males, whereas males had higher levels of octanoic acid compared to females.\u003c/p\u003e\n\u003cp\u003eSerum bile acid levels (\u0026micro;M) were also analyzed, many were reduced by antibiotic treatment, particularly for male rats (Table 4). For example, the mean serum cholic acid level for Male Control was 11.41 \u0026micro;M vs. 0.037 \u0026micro;M for Male Antibiotics. The mean serum cholic acid level for Female Control was 5.48 \u0026micro;M vs. 0.023 \u0026micro;M for Female Antibiotics. There were a wide range of serum cholic acid values for Male Control and particularly, Female Control. Therefore, a statistically significant difference for Female Control vs. Female Antibiotics was not determined. Male Antibiotics had significantly lower serum cholic acid levels compared to Male Control (\u003cem\u003ep\u003c/em\u003e = 0.0360). Raw values for all of these measurements are posted on FigShare: 10.6084/m9.figshare.30306424. Characterization of fecal SCFAs, serum SCFAs, and serum bile acids between males and females, with and without antibiotics, provides important information and characterization related to the gut microbiome and metabolism.\u003c/p\u003e\n\u003cp\u003eCorrelation analysis revealed significant associations between SCFA content, water, and home cage food consumption, and numerous specific microbial taxa (Figure 5A), whereas only a few genera were correlated with sex. SCFA content was positively correlated with 39 different genera, including the most abundant ones, such as \u003cem\u003eLactobacillus, Muribaculaceae, Romboutsia, Clostridia UCG-014, Bacteroides, and Ruminococcus\u003c/em\u003e. Consistent with previous results, fecal SCFA and its positively associated taxa decreased after the antibiotic treatment. Thus, SCFA content showed an inverse correlation with the genera that increase their abundances in the post-antibiotic conditions (i.e.: \u003cem\u003eClostridium sensu stricto, Escherichia-Shigella, Enterococcus, Staphylococcus\u003c/em\u003e, etc.).\u003c/p\u003e\n\u003cp\u003eTo further investigate the influence of hedonic feeding and related variables on microbial composition, a redundancy analysis (RDA) was performed (Figure 5B). The model identified propionic, isovaleric, and 2-methylbutyric acids as the most significant drivers of the community structure across treatments (adj. \u003cem\u003ep\u003c/em\u003e-value \u0026lt; 0.01). These 3 fatty acids were the main predictors of the microbial communities for pre-control, pre-antibiotics, and post-control samples, while they showed a negative association with post-antibiotic samples.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 2. Fecal SCFA Composition Analyses.\u003c/strong\u003e Mean fecal SCFA levels reported in nmol/mg. Pre-treatment: Male Control (n = 3), Male Antibiotics (n = 8), Female Control (n = 6), Female Antibiotics (n = 6). Post-treatment: Male Control (n = 5), Male Antibiotics (n = 8), Female Control (n = 5), Female Antibiotics (n = 7).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 3. Serum SCFA Composition Analyses\u003c/strong\u003e. Mean serum SCFA levels reported in \u0026micro;M. Male Control (n = 6), Male Antibiotics (n = 7), Female Control (n = 7), Female Antibiotics (n = 5).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 4. Serum Bile Acid Composition Analyses.\u003c/strong\u003e Mean serum bile acid levels reported in \u0026micro;M. Male Control (n = 6), Male Antibiotics (n = 7), Female Control (n = 6), Female Antibiotics (n = 5).\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eFirst, we determined that females have a higher demand at null cost for the high fat palatable reward compared to males. We have previously shown this sex difference [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. However, in our previous study, males and females were mildly food restricted in order to encourage lever pressing for the palatable rewards. Here, we provided ad libitum access to homecage food and continued to see lever pressing behavior to produce full demand curves. However, more males (n\u0026thinsp;=\u0026thinsp;11) failed to reach criteria during BE training with ad libitum homecage feeding compared to females (n\u0026thinsp;=\u0026thinsp;2) due to lower lever-pressing for the pellet, further supporting the finding that females have a higher demand for this palatable reward compared to males. Second, we characterized hedonic feeding, homecage feeding, fecal microbiome composition and diversity, serum and fecal SCFA composition, and serum bile acid composition following disruption of the gut microbiome with antibiotics. An antibiotic cocktail was utilized to disrupt the gut microbiome and test whether diversity of the gut microbiome impacted hedonic feeding behavior. In order to control for time between BE sessions as well as repeated sessions, we also included a subgroup of animals given normal drinking water for one month instead of the antibiotic cocktail. We did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. A mixed-effects analysis for time x sex x treatment and Tukey\u0026rsquo;s multiple comparisons test was applied; Female Control and Female Antibiotics had a significantly higher Q\u003csub\u003e0\u003c/sub\u003e value compared to Male Control pre-treatment. No significant differences were determined between Female Control and Female Antibiotics, Male Control and Male Antibiotics, or Male Antibiotics and Female Antibiotics pre-treatment. No statistically significant differences in Q\u003csub\u003e0\u003c/sub\u003e were determined for any group post-treatment. We did not determine any statistically significant differences in α between groups or between time points. Male Antibiotics had a slightly higher mean α value after antibiotics treatment, indicative of lower motivation, but that is not statistically significant. Importantly, this behavior analysis focused on hedonic feeding behavior; animals were not obese.\u003c/p\u003e \u003cp\u003eFemales consumed more water (normalized to their weight) during antibiotic treatment. Therefore, females received a higher dose of antibiotics compared to males. We noted temporary, reduced water consumption in male rats as well as weight loss, which may be related to an aversion to the taste of antibiotics. Previous work has shown that changes in drinking and feeding are not fully attributable to the bitter taste of antibiotics [\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e]. Studies have shown that females exhibit enhanced taste perception compared to males, particularly for bitter flavors, as well as sweet and salty tastes [\u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e, \u003cspan citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e]. Complementing enhanced taste perception for females, enhanced olfaction has also been shown for females [\u003cspan additionalcitationids=\"CR46\" citationid=\"CR45\" class=\"CitationRef\"\u003e45\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR47\" class=\"CitationRef\"\u003e47\u003c/span\u003e]. Therefore, decreased consumption of the antibiotic cocktail is likely not fully explained by taste aversion in males. In a study by Parodi et al. (2022), male and female Sprague-Dawley rats had significantly different responses to eight days of an antibiotic cocktail in their drinking water. Their antibiotic cocktail included the same antibiotics as our cocktail, however, it also included 1 g/L metronidazole. We chose not to include metronidazole in our current study given that it crosses the blood-brain barrier [\u003cspan citationid=\"CR48\" class=\"CitationRef\"\u003e48\u003c/span\u003e]. Similar to our findings, males and females exhibited significant differences in microbiome composition as well as body weight in response to the antibiotics. Their study also determined that males and females experienced weight loss during antibiotic treatment, however, females recovered their body weights after antibiotic treatment ended, while males did not [\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eWe collected fecal samples during both rounds of BE testing. We compared diversity and composition of the fecal microbiome between groups and time points. We, and others, have previously observed baseline sex differences in fecal microbiome composition and diversity for C57Bl/6 mice [\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e, \u003cspan additionalcitationids=\"CR50 CR51\" citationid=\"CR49\" class=\"CitationRef\"\u003e49\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR52\" class=\"CitationRef\"\u003e52\u003c/span\u003e]. We did not observe striking baseline sex differences in our current study with Sprague-Dawley rats. We hypothesized that sex differences in the gut microbiome contribute to sex differences in hedonic feeding. Given that there were no baseline sex differences in the fecal microbiome composition and disruption of the gut microbiome with antibiotics did not result in significant differences in hedonic feeding, our hypothesis was not supported. It may still be possible that the gut microbiome contributes to sex differences in hedonic feeding, even though our results do not support this claim. We consider a number of possibilities and limitations of our current study: 1) fecal samples were collected during BE testing in order to make within-animal comparisons (for example, pre-antibiotics and post-antibiotics within the same subject). A future study could, instead, collect samples directly from the colon to more accurately characterize aerobic and anaerobic bacteria. However, in this alternative experimental design, we could only evaluate behavior one time and then euthanize the animal to collect the samples. Still, there are other bacteria that are not fully captured with our current method. Furthermore, the gut microbiome is influenced by viruses, yeast, fungi, and archaea; there could be sex differences in these microorganisms that impact hedonic feeding. 2) Our current study evaluated adult rats and does not take into account the timeline during which the microbiome affects the circuitry for hedonic feeding. If the microbiome shapes hedonic feeding circuitry, it is likely that this occurs early in development. The behavioral economics paradigm was implemented during adulthood due to the complexity of the task and size of the operant chamber/position of levers that could be more difficult for younger rats to complete. The hedonic feeding circuitry could be less plastic during adulthood. 3) The antibiotic cocktail was administered in the drinking water. An alternative experimental design could include oral gavage of the antibiotics to control dosage. However, repeated oral gavage can be stressful and can affect the gastrointestinal tract. Therefore, we chose the less invasive strategy of antibiotic cocktail administration via their homecage water bottles. We did observe decreased consumption by male rats compared to female rats when we normalized consumption and dosage to body weight. Ultimately, we observed disruption of the fecal microbiome for both male and female rats. We also observed decreased SCFAs in male and female antibiotic-treated rats, indicating disruption of the gut microbiome to impact these metabolites in both sexes.\u003c/p\u003e \u003cp\u003eIn addition to analyzing fecal microbiome diversity and genus-level composition, we characterized fecal SCFAs, serum SCFAs, and serum bile acids. SCFA analysis can provide more information about microbiome metabolism. For example, it is known that \u003cem\u003eClostridium, Butyrivibrio\u003c/em\u003e, and \u003cem\u003eEubacterium\u003c/em\u003e are major producers of butyric acid [\u003cspan citationid=\"CR53\" class=\"CitationRef\"\u003e53\u003c/span\u003e]. Following antibiotic administration, we determined significant decreases in fecal and serum SCFAs for both males and females. We did determine a significant sex difference for serum iso-caproic acid for control groups and serum octanoic acid for antibiotic groups. Females had higher levels of iso-caproic acid compared to males, and higher levels following antibiotic treatment. Males had higher levels of octanoic acid compared to females, and higher levels following antibiotic treatment. We did not observe sex differences for these SCFAs in fecal samples. Fecal samples had significantly lower iso-caproic levels and octanoic acid levels for both sexes after antibiotics. However, in a previous study with C57Bl/6 mice we did observe a sex x dietary treatment/antibiotic treatment effect for fecal octanoic acid (among other SCFAs): males fed a low-fat diet had higher levels of octanoic acid than all other groups [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]. The observed differences in serum SCFAs in the current study could be due to differences in fatty acid metabolism, which has already been shown to be different in males and females [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e, \u003cspan citationid=\"CR54\" class=\"CitationRef\"\u003e54\u003c/span\u003e, \u003cspan citationid=\"CR55\" class=\"CitationRef\"\u003e55\u003c/span\u003e]. Fatty acid utilization, lipid sensing, and lipid taste can impact hedonic feeding [\u003cspan additionalcitationids=\"CR57\" citationid=\"CR56\" class=\"CitationRef\"\u003e56\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR58\" class=\"CitationRef\"\u003e58\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eWe further analyzed serum bile acid concentrations. Bile acids are synthesized in the liver, affect gastrointestinal hormone secretion, and they are also known to impact appetite, glucose metabolism, and lipid metabolism. For example, supplementation with cholic acid has been shown to reverse adiposity in mice administered a high fat diet [\u003cspan citationid=\"CR59\" class=\"CitationRef\"\u003e59\u003c/span\u003e]. In that study, chow-fed animals were not affected by the cholic acid supplementation. The high fat-fed, obese mice exhibited decreased white adipose tissue as well as improved glucose tolerance after cholic acid supplementation [\u003cspan citationid=\"CR59\" class=\"CitationRef\"\u003e59\u003c/span\u003e]. On the other hand, administration of deoxycholic acid to high fat-fed mice revealed increased hepatic ER stress, reduced hepatic insulin signaling, and impaired glucose homeostasis [\u003cspan citationid=\"CR60\" class=\"CitationRef\"\u003e60\u003c/span\u003e]. Bile acid subtypes have variable effects on glucose metabolism. Here, we determined significant changes to many bile acid subtypes following antibiotic administration, particularly for male rats. Antibiotics had less of an effect on bile acid concentrations for female rats. For example, cholic acid was significantly reduced in antibiotic-treated males (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.0360), but not in antibiotic-treated females (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.7208) because females already had lower levels of cholic acid. We also determined a significant sex difference: Female Control had higher levels of lithocholic acid compared to Male Control (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.0007). Lithocholic acid (LCA) was significantly reduced post-antibiotics for female rats (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.0020). Interestingly, LCA is increased after calorie restriction, it has been shown to activate AMPK [\u003cspan citationid=\"CR61\" class=\"CitationRef\"\u003e61\u003c/span\u003e], it decreases blood glucose levels, and it increases plasma GLP-1 levels [\u003cspan citationid=\"CR62\" class=\"CitationRef\"\u003e62\u003c/span\u003e]. Furthermore, it is known that \u003cem\u003eLactobacillus, Clostridium\u003c/em\u003e and \u003cem\u003eEubacterium\u003c/em\u003e species convert cholic acid and chenodeoxycholic acid to lithocholic acid [\u003cspan citationid=\"CR63\" class=\"CitationRef\"\u003e63\u003c/span\u003e]. We also determined significant sex differences in taurochenodeoxycholic (TCDCA). Females had higher levels of TCDCA compared to males, which increased even further with administration of antibiotics; that increase in TCDCA post-antibiotics was not observed for males. TCDCA is a conjugated bile acid that has been shown to increase following high fat feeding [\u003cspan citationid=\"CR64\" class=\"CitationRef\"\u003e64\u003c/span\u003e]. Previous work has demonstrated that microbiome changes due to high fat feeding can lead to increased TCDCA levels which can activate the farnesoid X receptor (FXR) and induce insulin resistance [\u003cspan citationid=\"CR64\" class=\"CitationRef\"\u003e64\u003c/span\u003e, \u003cspan citationid=\"CR65\" class=\"CitationRef\"\u003e65\u003c/span\u003e]. The composition of the gut microbiome has been shown to impact feeding behaviors. We did not determine major sex differences in the gut microbiome here that could contribute to our observed sex differences in hedonic feeding.\u003c/p\u003e"},{"header":"Conclusions","content":"\u003cp\u003eWe determined that female Sprague-Dawley rats have a higher demand at null cost for a high fat palatable reward compared to male Sprague-Dawley rats. We also determined that administration of antibiotics did not significantly change hedonic feeding behavior; however, sex differences in Q\u003csub\u003e0\u003c/sub\u003e values did not persist following antibiotic administration. Furthermore, we did not observe striking baseline sex differences for gut microbiome composition and diversity in our current study with Sprague-Dawley rats. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome \u0026ndash; bile acid effects on feeding that exhibit sex differences.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003eEthics approval and consent to participate: All protocols and procedures followed the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the Furman University Institutional Animal Care and Use Committee.\u003c/p\u003e\n\u003cp\u003eConsent for publication: Not applicable.\u003c/p\u003e\n\u003cp\u003eAvailability of data and material: Raw sequence data have been deposited in the Sequence Read Archive (Project PRJNA1337140): https://www.ncbi.nlm.nih.gov/sra?linkname=bioproject_sra_all\u0026amp;from_uid=1337140. The behavior, short chain fatty acid, and bile acid datasets are available at FigShare: 10.6084/m9.figshare.30306424.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eCompeting interests: The authors declare that they have no competing interests.\u003c/p\u003e\n\u003cp\u003eFunding: Research reported in this publication was supported by the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health under Award Number R15DK136098. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This publication was made possible, in part, with support from the Clemson University Genomics and Bioinformatics Facility, which receives support from the College of Science and two Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20GM146584 and P20GM139769.\u003c/p\u003e\n\u003cp\u003eAuthors\u0026apos; contributions: C.J.P., M.I., and L.P.P. conducted behavioral economics training and testing as well as animal husbandry. M.O. and S.M. conducted next-generation sequencing, statistical analyses, and contributed Figures 3, 4, 5, S2, and S3. L.R.F. obtained funding for the project, planned experiments, conducted analyses, helped draft the manuscript, and contributed the other figures. All authors contributed to the writing and editing of the manuscript. All authors read and approved the final manuscript.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAcknowledgments: We thank the Duke University School of Medicine for the use of the Proteomics and Metabolomics Core Facility, which provided short chain fatty acid and bile acid analysis service.\u003c/p\u003e\n\u003cp\u003eAuthors\u0026rsquo; information: Not applicable.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eAnversa RG, Muthmainah M, Sketriene D, Gogos A, Sumithran P, Brown RM. A review of sex differences in the mechanisms and drivers of overeating. Front Neuroendocrinol. 2021;63:100941. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.yfrne.2021.100941\u003c/span\u003e\u003cspan address=\"10.1016/j.yfrne.2021.100941\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAsarian L, Geary N. Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol. 2013;305 11:1215. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1152/ajpregu.00446.2012\u003c/span\u003e\u003cspan address=\"10.1152/ajpregu.00446.2012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEmmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023. NCHS Data Brief. doi 2024;508(508). \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.15620/cdc/159281\u003c/span\u003e\u003cspan address=\"10.15620/cdc/159281\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHardaway JA, Crowley NA, Bulik CM, Kash TL. Integrated circuits and molecular components for stress and feeding: implications for eating disorders. Genes Brain Behav. 2015;14 1:85\u0026ndash;97. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1111/gbb.12185\u003c/span\u003e\u003cspan address=\"10.1111/gbb.12185\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCarlin JL, McKee SE, Hill-Smith T, Grissom NM, George R, Lucki I, et al. Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice. Neuroscience. 2016;326:170\u0026ndash;9. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.neuroscience.2016.04.002\u003c/span\u003e\u003cspan address=\"10.1016/j.neuroscience.2016.04.002\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBabbs RK, Wojnicki FHE, Corwin RLW. Assessing binge eating. An analysis of data previously collected in bingeing rats. Appetite. 2012;59 2:478\u0026ndash;82. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.appet.2012.05.022\u003c/span\u003e\u003cspan address=\"10.1016/j.appet.2012.05.022\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGrimm JW, North K, Hopkins M, Jiganti K, McCoy A, Sulc J, et al. Sex differences in sucrose reinforcement in Long-Evans rats. Biol Sex Differ. 2022;13 1:3\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/s13293-022-00412-8\u003c/span\u003e\u003cspan address=\"10.1186/s13293-022-00412-8\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eFreeman LR, Bentzley BS, James MH, Aston-Jones G. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. Int J Neuropsychopharmacol. 2021;24 1:54\u0026ndash;63. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1093/ijnp/pyaa040\u003c/span\u003e\u003cspan address=\"10.1093/ijnp/pyaa040\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOusey J, Boktor JC, Mazmanian SK. Gut microbiota suppress feeding induced by palatable foods. Curr Biol. 2023;33. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.cub.2022.10.066\u003c/span\u003e\u003cspan address=\"10.1016/j.cub.2022.10.066\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. 1:147,157.e7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYu KB, Hsiao EY. Roles for the gut microbiota in regulating neuronal feeding circuits. J Clin Invest. 2021;131 10:e143772. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1172/JCI143772\u003c/span\u003e\u003cspan address=\"10.1172/JCI143772\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ede Wouters d'Oplinter A, Rastelli M, Van Hul M, Delzenne NM, Cani PD, Everard A. Gut microbes participate in food preference alterations during obesity. Gut Microbes. 2021;13(1:1959242). \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1080/19490976.2021.1959242\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2021.1959242\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePinart M, Dotsch A, Schlicht K, Laudes M, Bouwman J, Forslund SK, et al. Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis. Nutrients. 2021;14(1:12). \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3390/nu14010012\u003c/span\u003e\u003cspan address=\"10.3390/nu14010012\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBorin JM, Liu R, Wang Y, Wu T, Chopyk J, Huang L, et al. Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice. bioRxiv. 2023. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1101/2023.02.03.527064\u003c/span\u003e\u003cspan address=\"10.1101/2023.02.03.527064\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLeyrolle Q, Cserjesi R, Mulders MDGH, Zamariola G, Hiel S, Gianfrancesco MA, et al. Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients. Clin Nutr. 2021;40 4:2035\u0026ndash;44. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.clnu.2020.09.025\u003c/span\u003e\u003cspan address=\"10.1016/j.clnu.2020.09.025\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAgusti A, Campillo I, Balzano T, Benitez-Paez A, Lopez-Almela I, Romani-Perez M, et al. Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat. Mol Neurobiol. 2021;58 10:4959\u0026ndash;79. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s12035-021-02462-2\u003c/span\u003e\u003cspan address=\"10.1007/s12035-021-02462-2\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBabbs RK, Wojnicki FHE, Corwin RLW. Effect of 2-hydroxyestradiol on binge intake in rats. Physiol Behav. 2011;103 5:508\u0026ndash;12. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.physbeh.2011.03.029\u003c/span\u003e\u003cspan address=\"10.1016/j.physbeh.2011.03.029\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCason AM, Aston-Jones G. Role of orexin/hypocretin in conditioned sucrose-seeking in rats. Psychopharmacology. 2013;226 1:155\u0026ndash;65. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s00213-012-2902-y\u003c/span\u003e\u003cspan address=\"10.1007/s00213-012-2902-y\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCason AM, Aston-Jones G. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist. Psychopharmacology. 2013;228 3:499\u0026ndash;507. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1007/s00213-013-3051-7\u003c/span\u003e\u003cspan address=\"10.1007/s00213-013-3051-7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBello NT, Yeh C, James MH. Reduced Sensory-Evoked Locus Coeruleus-Norepinephrine Neural Activity in Female Rats With a History of Dietary-Induced Binge Eating. Front Psychol. 2019;10:1966; \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fpsyg.2019.01966\u003c/span\u003e\u003cspan address=\"10.3389/fpsyg.2019.01966\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKrohn TC, Sorensen DB, Otteson JL, Hansen AK. The effects of individual housing on mice and rats: a review. Anim Welf. 2006;15:4. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1017/S0962728600030669\u003c/span\u003e\u003cspan address=\"10.1017/S0962728600030669\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79 17:5112\u0026ndash;20. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1128/AEM.01043-13\u003c/span\u003e\u003cspan address=\"10.1128/AEM.01043-13\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37 8:852\u0026ndash;7. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/s41587-019-0209-9\u003c/span\u003e\u003cspan address=\"10.1038/s41587-019-0209-9\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCallahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13 7:581\u0026ndash;3. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/nmeth.3869\u003c/span\u003e\u003cspan address=\"10.1038/nmeth.3869\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKatoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform. 2008;9 4:286\u0026ndash;98. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1093/bib/bbn013\u003c/span\u003e\u003cspan address=\"10.1093/bib/bbn013\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHan J, Lin K, Sequeira C, Borchers CH. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2015;854:86\u0026ndash;94. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.aca.2014.11.015\u003c/span\u003e\u003cspan address=\"10.1016/j.aca.2014.11.015\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMcMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8 4:e61217. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0061217\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0061217\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOksanen J. Vegan: community ecology package. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://CRAN.R-project.org/package=vegan\u003c/span\u003e\u003cspan address=\"http://CRAN.R-project.org/package=vegan\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e (2010).\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLiu C, Mansoldo FRP, Li H, Vermelho AB, Zeng RJ, Li X, et al. A workflow for statistical analysis and visualization of microbiome omics data using the R microeco package. Nat Protoc. 2025. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/s41596-025-01239-4\u003c/span\u003e\u003cspan address=\"10.1038/s41596-025-01239-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAnderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecology. 2001;26 1; \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/j.1442-9993.2001.01070.pp.x\u003c/span\u003e\u003cspan address=\"10.1111/j.1442-9993.2001.01070.pp.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBenjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol). 1995. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/j.2517-6161.1995.tb02031.x\u003c/span\u003e\u003cspan address=\"10.1111/j.2517-6161.1995.tb02031.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. 57 1; doi.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRamette A. Multivariate analyses in microbial ecology. FEMS Microbiol Ecol. 2007;62 2:142\u0026ndash;60. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1111/j.1574-6941.2007.00375.x\u003c/span\u003e\u003cspan address=\"10.1111/j.1574-6941.2007.00375.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAnderson MJ. Distance-based tests for homogeneity of multivariate dispersions. Biometrics. 2006;62 1:245\u0026ndash;53. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1111/j.1541-0420.2005.00440.x\u003c/span\u003e\u003cspan address=\"10.1111/j.1541-0420.2005.00440.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSegata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12 6:R60\u0026ndash;60. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/gb-2011-12-6-r60\u003c/span\u003e\u003cspan address=\"10.1186/gb-2011-12-6-r60\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBastian M, Heymann S, Jacomy M. Gephi: An Open Source Software for Exploring and Manipulating Networks. Mar 19 2009:361\u0026ndash;2.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eStapleton S, Welch G, DiBerardo L, Freeman LR. Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome. Biol Sex Differ. 2024;15 1:5\u0026ndash;1. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1186/s13293-023-00580-1\u003c/span\u003e\u003cspan address=\"10.1186/s13293-023-00580-1\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDeshpande NG, Saxena J, Pesaresi TG, Carrell CD, Ashby GB, Liao M, et al. High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats. PLoS ONE. 2019;14 5:e0217553. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0217553\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0217553\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZimmerman DR. Role of subtherapeutic levels of antimicrobials in pig production. J Anim Sci. 1986;62 3:6\u0026ndash;16.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eParodi G, Leite G, Pimentel ML, Barlow GM, Fiorentino A, Morales W, et al. The Response of the Rodent Gut Microbiome to Broad-Spectrum Antibiotics Is Different in Males and Females. Front Microbiol. 2022;13:897283. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fmicb.2022.897283\u003c/span\u003e\u003cspan address=\"10.3389/fmicb.2022.897283\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAzad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond). 2014;38 10:1290\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/ijo.2014.119\u003c/span\u003e\u003cspan address=\"10.1038/ijo.2014.119\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMurphy R, Stewart AW, Braithwaite I, Beasley R, Hancox RJ, Mitchell EA, et al. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int J Obes (Lond). 2014;38 8:1115\u0026ndash;9. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/ijo.2013.218\u003c/span\u003e\u003cspan address=\"10.1038/ijo.2013.218\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSaari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015;135 4:617\u0026ndash;26. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1542/peds.2014-3407\u003c/span\u003e\u003cspan address=\"10.1542/peds.2014-3407\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBongers KS, McDonald RA, Winner KM, Falkowski NR, Brown CA, Baker JM, et al. Antibiotics cause metabolic changes in mice primarily through microbiome modulation rather than behavioral changes. PLoS ONE. 2022;17 3:e0265023. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0265023\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0265023\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRosa A, Pinna I, Piras A, Porcedda S, Masala C. Sex Differences in the Bitterness Perception of an Aromatic Myrtle Bitter Liqueur and Bitter Compounds. Nutrients. 2023;15. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3390/nu15092030\u003c/span\u003e\u003cspan address=\"10.3390/nu15092030\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. 9:2030.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWang J, Liang K, Lin W, Chen C, Jiang R. Influence of age and sex on taste function of healthy subjects. PLoS ONE. 2020;15 6:e0227014. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0227014\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0227014\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSorokowski P, Karwowski M, Misiak M, Marczak MK, Dziekan M, Hummel T, et al. Sex Differences in Human Olfaction: A Meta-Analysis. Front Psychol. 2019;10:242. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fpsyg.2019.00242\u003c/span\u003e\u003cspan address=\"10.3389/fpsyg.2019.00242\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMaheshwar KV, Stuart AE, Kay LM. Sex differences in olfactory behavior and neurophysiology in Long Evans rats. J Neurophysiol. 2025;133 1:257\u0026ndash;67. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1152/jn.00222.2024\u003c/span\u003e\u003cspan address=\"10.1152/jn.00222.2024\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKass MD, Czarnecki LA, Moberly AH, McGann JP. Differences in peripheral sensory input to the olfactory bulb between male and female mice. Sci Rep. 2017;7:45851. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/srep45851\u003c/span\u003e\u003cspan address=\"10.1038/srep45851\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eJokipii AM, Myllyla VV, Hokkanen E, Jokipii L. Penetration of the blood brain barrier by metronidazole and tinidazole. J Antimicrob Chemother. 1977;3 3:239\u0026ndash;45. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1093/jac/3.3.239\u003c/span\u003e\u003cspan address=\"10.1093/jac/3.3.239\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDaly CM, Saxena J, Singh J, Bullard MR, Bondy EO, Saxena A, et al. Sex differences in response to a high fat, high sucrose diet in both the gut microbiome and hypothalamic astrocytes and microglia. Nutr Neurosci. 2022;25 2:321\u0026ndash;35. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1080/1028415X.2020.1752996\u003c/span\u003e\u003cspan address=\"10.1080/1028415X.2020.1752996\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSaxena A, Moran RRM, Bullard MR, Bondy EO, Smith MF, Morris L, et al. Sex differences in the fecal microbiome and hippocampal glial morphology following diet and antibiotic treatment. PLoS ONE. 2022;17(4):e0265850. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0265850\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0265850\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eOrg E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, et al. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016;7 4:313\u0026ndash;22. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1080/19490976.2016.1203502\u003c/span\u003e\u003cspan address=\"10.1080/19490976.2016.1203502\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMarkle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339 6123:1084\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1126/science.1233521\u003c/span\u003e\u003cspan address=\"10.1126/science.1233521\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSingh V, Lee G, Son H, Koh H, Kim ES, Unno T, et al. Butyrate producers, The Sentinel of Gut: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol. 2023;13:1103836. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fmicb.2022.1103836\u003c/span\u003e\u003cspan address=\"10.3389/fmicb.2022.1103836\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDecsi T, Kennedy K. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr. 2011;94. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3945/ajcn.110.000893\u003c/span\u003e\u003cspan address=\"10.3945/ajcn.110.000893\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. 6 Suppl:1914S\u0026ndash;9S.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSantosa S, Jensen MD. The Sexual Dimorphism of Lipid Kinetics in Humans. Front Endocrinol (Lausanne). 2015;6:103. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fendo.2015.00103\u003c/span\u003e\u003cspan address=\"10.3389/fendo.2015.00103\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eTauber JM, Brown EB, Li Y, Yurgel ME, Masek P, Keene AC. A subset of sweet-sensing neurons identified by IR56d are necessary and sufficient for fatty acid taste. PLoS Genet. 2017;13 11:e1007059. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pgen.1007059\u003c/span\u003e\u003cspan address=\"10.1371/journal.pgen.1007059\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCoccurello R, Maccarrone M. Hedonic Eating and the Delicious Circle: From Lipid-Derived Mediators to Brain Dopamine and Back. Front Neurosci. 2018;12:271. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.3389/fnins.2018.00271\u003c/span\u003e\u003cspan address=\"10.3389/fnins.2018.00271\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWoodward ORM, Gribble FM, Reimann F, Lewis JE. Gut peptide regulation of food intake - evidence for the modulation of hedonic feeding. J Physiol. 2022;600 5:1053\u0026ndash;78. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1113/JP280581\u003c/span\u003e\u003cspan address=\"10.1113/JP280581\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWatanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439 7075:484\u0026ndash;9. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/nature04330\u003c/span\u003e\u003cspan address=\"10.1038/nature04330\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZaborska KE, Lee SA, Garribay D, Cha E, Cummings BP. Deoxycholic acid supplementation impairs glucose homeostasis in mice. PLoS ONE. 2018;13 7:e0200908. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1371/journal.pone.0200908\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0200908\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCokorinos EC, Delmore J, Reyes AR, Albuquerque B, Kjobsted R, Jorgensen NO, et al. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. 2017;25 5:11471159e10. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.cmet.2017.04.010\u003c/span\u003e\u003cspan address=\"10.1016/j.cmet.2017.04.010\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eQu Q, Chen Y, Wang Y, Long S, Wang W, Yang H, et al. Author Correction: Lithocholic acid phenocopies anti-ageing effects of calorie restriction. Nature. 2025;638 8050:E6\u0026ndash;w. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1038/s41586-025-08693-w\u003c/span\u003e\u003cspan address=\"10.1038/s41586-025-08693-w\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.pharmthera.2022.108238\u003c/span\u003e\u003cspan address=\"10.1016/j.pharmthera.2022.108238\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhang S, Li RJW, Lim Y, Batchuluun B, Liu H, Waise TMZ, et al. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut. 2021;70 9:1675\u0026ndash;83. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1136/gutjnl-2020-321757\u003c/span\u003e\u003cspan address=\"10.1136/gutjnl-2020-321757\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWaise TMZ, Lim Y, Danaei Z, Zhang S, Lam TKT. Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats. Mol Metab. 2021;44:101132. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003e10.1016/j.molmet.2020.101132\u003c/span\u003e\u003cspan address=\"10.1016/j.molmet.2020.101132\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"},{"header":"Tables","content":"\u003cp\u003eTables 1 to 4 are available in the Supplementary Files section.\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"biology-of-sex-differences","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bosd","sideBox":"Learn more about [Biology of Sex Differences](http://bsd.biomedcentral.com)","snPcode":"13293","submissionUrl":"https://submission.nature.com/new-submission/13293/3","title":"Biology of Sex Differences","twitterHandle":"@BiologySexDiff","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"gut microbiome, hedonic feeding, sex differences, antibiotics, behavioral economics, short chain fatty acids, bile acids","lastPublishedDoi":"10.21203/rs.3.rs-9557496/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-9557496/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e \u003cp\u003eObesity continues to be a public health issue in our country. Additionally, there continues to be a higher incidence of severe obesity for women compared to men. Among the proposed causes of obesity is increased hedonic feeding: food intake driven by pleasure and palatability rather than physiological hunger. While hedonic feeding is not the sole culprit for the obesity epidemic, it is a major contributing factor. Emerging evidence shows that the gut microbiome impacts feeding behavior and studies have shown that individuals with obesity exhibit an altered gut microbiome.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e \u003cp\u003eHere, we used a novel behavioral economics (BE) approach to evaluate hedonic feeding in male and female Sprague-Dawley rats for a high-fat palatable (HFP) reward pellet, before and after antibiotic administration. Specifically, we measured demand elasticity (α), the rate at which demand falls when the price or effort required increases, and demand at null cost (Q\u003csub\u003e0\u003c/sub\u003e), a prediction of consumption at null effort extrapolated from the animals\u0026rsquo; consumption at low price.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e \u003cp\u003eWe determined a higher demand at null cost (Q\u003csub\u003e0\u003c/sub\u003e) for the HFP reward pellet for females compared to males, as we have observed previously. Next, we administered an antibiotic cocktail in the drinking water to disrupt the gut microbiome and investigate a role of the gut microbiome in hedonic feeding. Female rats administered antibiotics continued to have a higher demand at null cost compared to male control rats, but no statistically significant differences were determined between male and female rats administered antibiotics. We characterized the fecal microbiome genus-level composition and short chain fatty acid (SCFA) levels before and after antibiotic administration. We also characterized serum SCFA and bile acid levels at the end of the study.\u003c/p\u003e\u003ch2\u003eConclusions\u003c/h2\u003e \u003cp\u003eWe did not determine a significant effect of antibiotics on hedonic feeding, despite disruption to the fecal microbiome. Additionally, we did not observe striking baseline sex differences in fecal microbiome diversity and composition. This brings to question whether the gut microbiome contributes to sex differences in hedonic feeding. More research will be necessary for network factors such as microbiome \u0026ndash; bile acid effects on feeding that exhibit sex differences.\u003c/p\u003e","manuscriptTitle":"Sex differences in hedonic feeding and characterizing the effects of antibiotic-induced microbiome disruption","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-05-11 12:25:55","doi":"10.21203/rs.3.rs-9557496/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"reviewersInvited","content":"","date":"2026-05-01T15:29:49+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-05-01T13:34:56+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2026-05-01T13:34:34+00:00","index":"","fulltext":""},{"type":"submitted","content":"Biology of Sex Differences","date":"2026-04-28T18:23:49+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"biology-of-sex-differences","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bosd","sideBox":"Learn more about [Biology of Sex Differences](http://bsd.biomedcentral.com)","snPcode":"13293","submissionUrl":"https://submission.nature.com/new-submission/13293/3","title":"Biology of Sex Differences","twitterHandle":"@BiologySexDiff","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"eca73c39-2cba-4cc4-aad7-aac552cd9df3","owner":[],"postedDate":"May 11th, 2026","published":true,"recentEditorialEvents":[{"type":"reviewersInvited","content":"10","date":"2026-05-01T15:29:49+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-05-01T13:34:56+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2026-05-01T13:34:34+00:00","index":"","fulltext":""}],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2026-05-11T12:25:56+00:00","versionOfRecord":[],"versionCreatedAt":"2026-05-11 12:25:55","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-9557496","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-9557496","identity":"rs-9557496","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.